WO1998003272A1 - Processes for the preparation of 4-amino-5-chloro-6-(1-fluoroethyl)pyrimidine compounds - Google Patents
Processes for the preparation of 4-amino-5-chloro-6-(1-fluoroethyl)pyrimidine compounds Download PDFInfo
- Publication number
- WO1998003272A1 WO1998003272A1 PCT/JP1997/002475 JP9702475W WO9803272A1 WO 1998003272 A1 WO1998003272 A1 WO 1998003272A1 JP 9702475 W JP9702475 W JP 9702475W WO 9803272 A1 WO9803272 A1 WO 9803272A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- carbon atoms
- compound
- chloro
- atom
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 28
- 238000002360 preparation method Methods 0.000 title claims 2
- MSCXOYUJINNDKZ-UHFFFAOYSA-N 5-chloro-6-(1-fluoroethyl)pyrimidin-4-amine Chemical class CC(F)C1=NC=NC(N)=C1Cl MSCXOYUJINNDKZ-UHFFFAOYSA-N 0.000 title abstract description 3
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 claims abstract description 30
- 239000011698 potassium fluoride Substances 0.000 claims abstract description 15
- 235000003270 potassium fluoride Nutrition 0.000 claims abstract description 15
- 125000004432 carbon atom Chemical group C* 0.000 claims description 94
- 150000001875 compounds Chemical class 0.000 claims description 84
- 125000000217 alkyl group Chemical group 0.000 claims description 40
- 238000006243 chemical reaction Methods 0.000 claims description 40
- 125000005843 halogen group Chemical group 0.000 claims description 38
- 239000000203 mixture Substances 0.000 claims description 35
- -1 iminobenzyl group Chemical group 0.000 claims description 33
- 239000002904 solvent Substances 0.000 claims description 31
- 238000004519 manufacturing process Methods 0.000 claims description 24
- 125000001188 haloalkyl group Chemical group 0.000 claims description 19
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims description 18
- 125000003545 alkoxy group Chemical group 0.000 claims description 18
- 125000001424 substituent group Chemical group 0.000 claims description 15
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 claims description 14
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 claims description 12
- 229910052799 carbon Inorganic materials 0.000 claims description 10
- 229910052783 alkali metal Inorganic materials 0.000 claims description 9
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 9
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 7
- 150000001340 alkali metals Chemical class 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 6
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 5
- 150000001721 carbon Chemical group 0.000 claims description 5
- 125000004438 haloalkoxy group Chemical group 0.000 claims description 5
- 125000004076 pyridyl group Chemical group 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- RXMRGBVLCSYIBO-UHFFFAOYSA-M tetramethylazanium;iodide Chemical compound [I-].C[N+](C)(C)C RXMRGBVLCSYIBO-UHFFFAOYSA-M 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 3
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 3
- 125000000304 alkynyl group Chemical group 0.000 claims description 3
- 125000000262 haloalkenyl group Chemical group 0.000 claims description 3
- 125000004692 haloalkylcarbonyl group Chemical group 0.000 claims description 3
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 claims description 2
- KZKGLGIVGQYOTG-UHFFFAOYSA-N [F].[Au] Chemical class [F].[Au] KZKGLGIVGQYOTG-UHFFFAOYSA-N 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 claims description 2
- 125000004414 alkyl thio group Chemical group 0.000 claims description 2
- CHQVQXZFZHACQQ-UHFFFAOYSA-M benzyl(triethyl)azanium;bromide Chemical compound [Br-].CC[N+](CC)(CC)CC1=CC=CC=C1 CHQVQXZFZHACQQ-UHFFFAOYSA-M 0.000 claims description 2
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 claims description 2
- KXHPPCXNWTUNSB-UHFFFAOYSA-M benzyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1=CC=CC=C1 KXHPPCXNWTUNSB-UHFFFAOYSA-M 0.000 claims description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 2
- DDFYFBUWEBINLX-UHFFFAOYSA-M tetramethylammonium bromide Chemical compound [Br-].C[N+](C)(C)C DDFYFBUWEBINLX-UHFFFAOYSA-M 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- HIPXPABRMMYVQD-UHFFFAOYSA-N n-benzylbutan-1-amine Chemical compound CCCCNCC1=CC=CC=C1 HIPXPABRMMYVQD-UHFFFAOYSA-N 0.000 claims 1
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 claims 1
- UQFSVBXCNGCBBW-UHFFFAOYSA-M tetraethylammonium iodide Chemical compound [I-].CC[N+](CC)(CC)CC UQFSVBXCNGCBBW-UHFFFAOYSA-M 0.000 claims 1
- KKLAORVGAKUOPZ-UHFFFAOYSA-M trimethyl(phenyl)azanium;iodide Chemical compound [I-].C[N+](C)(C)C1=CC=CC=C1 KKLAORVGAKUOPZ-UHFFFAOYSA-M 0.000 claims 1
- CRSWJMRRJRRGET-UHFFFAOYSA-N 5-chloro-6-(1-chloroethyl)-n-(2-phenylethyl)pyrimidin-4-amine Chemical compound CC(Cl)C1=NC=NC(NCCC=2C=CC=CC=2)=C1Cl CRSWJMRRJRRGET-UHFFFAOYSA-N 0.000 abstract 1
- DANOJLRCRKMOOT-UHFFFAOYSA-N 6-(1-bromoethyl)-5-chloro-n-(2-phenylethyl)pyrimidin-4-amine Chemical compound CC(Br)C1=NC=NC(NCCC=2C=CC=CC=2)=C1Cl DANOJLRCRKMOOT-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 133
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 108
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 45
- 230000015572 biosynthetic process Effects 0.000 description 27
- 229910052801 chlorine Inorganic materials 0.000 description 27
- 238000003786 synthesis reaction Methods 0.000 description 27
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 26
- 229910052731 fluorine Inorganic materials 0.000 description 26
- 229910052740 iodine Inorganic materials 0.000 description 26
- 125000001309 chloro group Chemical group Cl* 0.000 description 23
- 238000004440 column chromatography Methods 0.000 description 23
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 22
- 125000001153 fluoro group Chemical group F* 0.000 description 22
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 18
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 17
- 238000010828 elution Methods 0.000 description 17
- 239000013078 crystal Substances 0.000 description 16
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 15
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- 239000010410 layer Substances 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 125000001478 1-chloroethyl group Chemical group [H]C([H])([H])C([H])(Cl)* 0.000 description 9
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 229940125904 compound 1 Drugs 0.000 description 5
- 229940126543 compound 14 Drugs 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 4
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- KIWBPDUYBMNFTB-UHFFFAOYSA-M ethyl sulfate Chemical compound CCOS([O-])(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-M 0.000 description 4
- 239000011737 fluorine Substances 0.000 description 4
- UZGLIIJVICEWHF-UHFFFAOYSA-N octogen Chemical group [O-][N+](=O)N1CN([N+]([O-])=O)CN([N+]([O-])=O)CN([N+]([O-])=O)C1 UZGLIIJVICEWHF-UHFFFAOYSA-N 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 125000006083 1-bromoethyl group Chemical group 0.000 description 3
- 125000004776 1-fluoroethyl group Chemical group [H]C([H])([H])C([H])(F)* 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 229940125782 compound 2 Drugs 0.000 description 3
- 229940126214 compound 3 Drugs 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 125000004440 haloalkylsulfinyl group Chemical group 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- MYFFAYOTMYKXDK-UHFFFAOYSA-N n-(2-phenylethyl)pyrimidin-2-amine Chemical compound N=1C=CC=NC=1NCCC1=CC=CC=C1 MYFFAYOTMYKXDK-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 125000005554 pyridyloxy group Chemical group 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 3
- ZQXCQTAELHSNAT-UHFFFAOYSA-N 1-chloro-3-nitro-5-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC(Cl)=CC(C(F)(F)F)=C1 ZQXCQTAELHSNAT-UHFFFAOYSA-N 0.000 description 2
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 2
- QPUYECUOLPXSFR-UHFFFAOYSA-N 1-methylnaphthalene Chemical compound C1=CC=C2C(C)=CC=CC2=C1 QPUYECUOLPXSFR-UHFFFAOYSA-N 0.000 description 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 2
- 125000003302 alkenyloxy group Chemical group 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 229910052792 caesium Inorganic materials 0.000 description 2
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 2
- 239000007806 chemical reaction intermediate Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012025 fluorinating agent Substances 0.000 description 2
- 125000005280 halo alkyl sulfonyloxy group Chemical group 0.000 description 2
- 125000004995 haloalkylthio group Chemical group 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- YBRFXXOAQGWDOE-UHFFFAOYSA-N n-[2-(4-methoxyphenyl)ethyl]pyrimidin-2-amine Chemical compound C1=CC(OC)=CC=C1CCNC1=NC=CC=N1 YBRFXXOAQGWDOE-UHFFFAOYSA-N 0.000 description 2
- ZTXXSJFPOPSLDM-UHFFFAOYSA-N n-[2-[4-(trifluoromethoxy)phenyl]ethyl]pyrimidin-2-amine Chemical compound C1=CC(OC(F)(F)F)=CC=C1CCNC1=NC=CC=N1 ZTXXSJFPOPSLDM-UHFFFAOYSA-N 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 239000003444 phase transfer catalyst Substances 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- RQXXCWHCUOJQGR-UHFFFAOYSA-N 1,1-dichlorohexane Chemical compound CCCCCC(Cl)Cl RQXXCWHCUOJQGR-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- CVHZFUADPTWUGY-UHFFFAOYSA-N 1-(5,6-dichloropyrimidin-4-yl)ethanol Chemical compound CC(O)C1=NC=NC(Cl)=C1Cl CVHZFUADPTWUGY-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- QIFRTOLUDKTRIJ-UHFFFAOYSA-N 4,5-dichloro-6-(1-chloroethyl)pyrimidine Chemical compound CC(Cl)C1=NC=NC(Cl)=C1Cl QIFRTOLUDKTRIJ-UHFFFAOYSA-N 0.000 description 1
- RPVZESOQOOPTGU-UHFFFAOYSA-N 4,5-dichloro-6-ethylpyrimidine Chemical compound CCC1=NC=NC(Cl)=C1Cl RPVZESOQOOPTGU-UHFFFAOYSA-N 0.000 description 1
- NHTURKUJYDHMIQ-UHFFFAOYSA-N 4,5-dichloropyrimidine Chemical compound ClC1=CN=CN=C1Cl NHTURKUJYDHMIQ-UHFFFAOYSA-N 0.000 description 1
- VKJXAQYPOTYDLO-UHFFFAOYSA-N 4-methylphenethylamine Chemical compound CC1=CC=C(CCN)C=C1 VKJXAQYPOTYDLO-UHFFFAOYSA-N 0.000 description 1
- CVICEEPAFUYBJG-UHFFFAOYSA-N 5-chloro-2,2-difluoro-1,3-benzodioxole Chemical group C1=C(Cl)C=C2OC(F)(F)OC2=C1 CVICEEPAFUYBJG-UHFFFAOYSA-N 0.000 description 1
- LRMGTGJUUSVYGN-UHFFFAOYSA-N 5-chloro-6-(1-fluoroethyl)-n-[2-(4-methylphenyl)ethyl]pyrimidin-4-amine Chemical compound CC(F)C1=NC=NC(NCCC=2C=CC(C)=CC=2)=C1Cl LRMGTGJUUSVYGN-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- VCZLWWHHEBKQDS-UHFFFAOYSA-N CC1=CC=C(C=C1)CCNC1=NC=CC=N1 Chemical compound CC1=CC=C(C=C1)CCNC1=NC=CC=N1 VCZLWWHHEBKQDS-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical group CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- ABRVLXLNVJHDRQ-UHFFFAOYSA-N [2-pyridin-3-yl-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound FC(C1=CC(=CC(=N1)C=1C=NC=CC=1)CN)(F)F ABRVLXLNVJHDRQ-UHFFFAOYSA-N 0.000 description 1
- 230000000895 acaricidal effect Effects 0.000 description 1
- 239000000642 acaricide Substances 0.000 description 1
- XVUDRSZQKGTCPH-UHFFFAOYSA-N acetic acid;n,n-dimethylformamide Chemical compound CC(O)=O.CN(C)C=O XVUDRSZQKGTCPH-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000005133 alkynyloxy group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- VJGNLOIQCWLBJR-UHFFFAOYSA-M benzyl(tributyl)azanium;chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CC1=CC=CC=C1 VJGNLOIQCWLBJR-UHFFFAOYSA-M 0.000 description 1
- SXGBREZGMJVYRL-UHFFFAOYSA-N butan-1-amine;hydrobromide Chemical compound [Br-].CCCC[NH3+] SXGBREZGMJVYRL-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 229940125878 compound 36 Drugs 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Substances CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- WSLQHGMJTGELSF-UHFFFAOYSA-L dipotassium;difluoride Chemical compound [F-].[F-].[K+].[K+] WSLQHGMJTGELSF-UHFFFAOYSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- XWBDWHCCBGMXKG-UHFFFAOYSA-N ethanamine;hydron;chloride Chemical compound Cl.CCN XWBDWHCCBGMXKG-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- XUCNUKMRBVNAPB-UHFFFAOYSA-N fluoroethene Chemical group FC=C XUCNUKMRBVNAPB-UHFFFAOYSA-N 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 125000005291 haloalkenyloxy group Chemical group 0.000 description 1
- 125000004441 haloalkylsulfonyl group Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical compound O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 150000002641 lithium Chemical class 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- RUGOPPWUFGEYNK-UHFFFAOYSA-N n-[2-(4-methoxyphenyl)ethyl]pyrimidin-4-amine Chemical compound C1=CC(OC)=CC=C1CCNC1=CC=NC=N1 RUGOPPWUFGEYNK-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000005645 nematicide Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 125000003395 phenylethylamino group Chemical group [H]N(*)C([H])([H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000005415 substituted alkoxy group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
- HWCKGOZZJDHMNC-UHFFFAOYSA-M tetraethylammonium bromide Chemical compound [Br-].CC[N+](CC)(CC)CC HWCKGOZZJDHMNC-UHFFFAOYSA-M 0.000 description 1
- UBOXGVDOUJQMTN-UHFFFAOYSA-N trichloroethylene Natural products ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- GNMJFQWRASXXMS-UHFFFAOYSA-M trimethyl(phenyl)azanium;bromide Chemical compound [Br-].C[N+](C)(C)C1=CC=CC=C1 GNMJFQWRASXXMS-UHFFFAOYSA-M 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
Definitions
- the present invention relates to a method for producing a 4-amino-5-chloro-6-O-fluroyl pyrimidine compound which is useful as a medicament or a drug, and more particularly, to an industrially advantageous method for producing this compound.
- a 4-amino-5-chloro-6-O-fluroyl pyrimidine compound which is useful as a medicament or a drug, and more particularly, to an industrially advantageous method for producing this compound.
- Numerous compounds are known as the 4-amino-5-chloro-6- (1-1 full-year-old rotyl) pyrimidine compound produced by the present invention, and insecticides, acaricides, and? It is also known to be useful as an S fungicide, a nematicide, etc. (for example, Japanese Patent Application Laid-Open Nos. 5-194417, 5-23036, Japanese Unexamined Patent Publication No. Hei 6—2,5187, Japanese Unexamined Patent Publication No. Hei 6-116,247, Japanese Unexamined Patent Publication No. Hei 6-247939, Japanese Unexamined Patent Publication No. Hei 7-258,223, Japanese Patent Application Laid-Open No. H08-113135, etc.).
- A represents an alkyl group, an aralkyl group, a cycloalkyl group, or the like, and is a method of reacting with various amines represented by.
- reaction intermediate 4-halogeno 5-chloro-6- (1-1 full-year rotyl) pyrimidine, is disclosed in JP-A-5-194417.
- R 2 represents a lower acyl group
- M represents an alkali metal
- the target compound can be produced by a method of reacting a fluorinating agent represented by
- the target compound can be produced by a method of reacting with an alkali gold fluorine compound represented by the following formula.
- this method uses N, N-dimethylformamide (DMF), N, N-dimethylacetamide (DMA), 1,3-dimethyl-2-imidazolidone, dimethylsulfoxide, sulfolane and mixtures thereof as solvents.
- DMF N, N-dimethylformamide
- DMA N, N-dimethylacetamide
- 1,3-dimethyl-2-imidazolidone dimethylsulfoxide
- sulfolane 1,3-dimethyl-2-imidazolidone
- this manufacturing method is also not an industrial manufacturing method.
- An object of the present invention is to provide an industrial production method of a 4-amino-5-chloro-6- (1 -full-year-old rotyl) pyrimidine compound useful as a medicine and a pesticide. Disclosure of the invention
- the present invention is as follows.
- R is a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a halogen atom, an unsubstituted or halogen atom, a carbon atom having 1 to 4 alkyl groups, An alkoxy group having 1 to 4 carbon atoms, a benzoyl group having at least one of haloalkyl groups having 1 to 4 carbon atoms as a substituent, a haloalkyl group having 1 to 4 carbon atoms, Octoalkoxy, halo with 2 to 5 carbon atoms Alkylcarbonyl group, alkylsulfonyloxy group having 1 to 4 carbon atoms, haloalkylsulfonyloxy group having 1 to 4 carbon atoms, (alkoxy group having 1 to 4 carbon atoms) iminobenzyl group, 2-phenyl At least one of a 1,3-dioxolanyl group, an alkoxy
- alkylcarbonyl group having 1 to 4 carbon atoms Represents an alkynyl group having 2 to 5 carbon
- M represents an alkali metal
- alkali metal fluorine compounds represented by
- R 1 represents an alkyl group having 4 to 4 carbon atoms, a benzyl group or a phenyl group, and X is as defined above.
- the present invention relates to a method for producing a 4-amino-5-chloro-6- (1-fluoroethyl) pyrimidine compound represented by the formula:
- the invention further provides:
- R ′ is a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a halogen atom, a haloalkyl group having 1 to 4 carbon atoms, and a carbon atom having 1 to 4 carbon atoms.
- M represents an alkali metal
- R ′ is as defined above
- the present invention relates to a method for producing a 4-amino-5-chloro- (11-full-year rotyl) pyrimidine compound represented by the formula: BEST MODE FOR CARRYING OUT THE INVENTION
- R represents a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a halogen atom, a benzoyl group, a haloalkyl group having 1 to 4 carbon atoms, a carbon atom of 1 to 4 carbon atoms.
- alkyl group examples include a linear or branched alkyl group; preferably an alkyl group having 1 to 4 carbon atoms; and more preferably CH 3 and t-C 4 H 9 .
- Alkoxy groups include linear or branched ones; preferably those having 1 to 4 carbon atoms; more preferably —OCH 3 and 1 OC 2 H 5 .
- halogen atom examples include a fluorine atom, a chlorine atom, an iodine atom and an iodine atom; preferred are a fluorine atom and a chlorine atom.
- Examples of the benzoyl group include unsubstituted and substituted groups.
- Examples of the S-substituent include a halogen) atom, an alkyl group having 4 to 4 carbon atoms, an alkoxy group having 4 to 4 carbon atoms, and a haloalkyl group having 1 to 4 carbon atoms. it can.
- the position of the substituent in the benzoyl group is not particularly limited; however, the 3_ position or the 4 position is preferable.
- Substituted halogen atoms in the benzoyl group include fluorine, chlorine, bromine and iodine; fluorine and chlorine are preferred.
- the dialkyl group in the benzoyl group may be linear or branched; preferably it has 1 to 4 carbon atoms; and more preferably CH 3 .
- Examples of the substituted alkoxy group in the benzoyl group include straight-chain or branched ones; preferably one having 1 to 4 carbon atoms; more preferably —OCH 3 T.
- alkyl has 1 to 4 carbon atoms.
- examples thereof include linear or branched ones having a halogen atom such as a fluorine atom, a chlorine atom, a bromine urine, and an iodine atom; preferably, CF 3 is used.
- the haloalkyl group include those in which alkyl is linear or branched having 1 to 4 carbon atoms and has a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom and an iodine atom. ; it is preferably CF 3.
- haloalkoxy group examples include those in which alkoxy is straight or branched having 4 to 4 carbon atoms and having a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom and an iodine atom; preferably an OC F 3, -OCH F 2, - O CH 2 CF 3, -OC F 2 CHFCF 3, -OCH FCH F 2, - a OC F 2 CH FC I and single OC B r F 2.
- a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom and an iodine atom
- haloalkylcarbonyl group examples include those in which alkyl is linear or branched having 1 to 4 carbon atoms and having an octagen atom such as a fluorine atom, a chlorine atom, a bromine atom and an iodine atom; preferably an COC F 3.
- alkylsulfonyl group examples include those having a linear or branched alkyl group; preferably, it is OS 2 CH 3 .
- haloalkylsulfonyloxy group examples include those in which the alkyl is linear or branched having 1 to 4 carbon atoms and has a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom and an iodine atom. But preferably one OS 0 2 CF 3 .
- iminobenzyl group examples include those having an alkoxy group having 1 to 4 carbon atoms. And, as this alkoxy group, preferably one OCH
- Examples of the 2-phenyl-3-dioxolanyl group include unsubstituted and those having a halogen atom as a substituent.
- the position of the substituent in the 2-phenyl 1,3-dioxolanyl group is not particularly limited; however, the 4-position of the phenyl moiety is preferred.
- Examples of the substituted halogen atom in the 2-phenyl-1,3-dioxolanyl group include a fluorine atom, a chlorine atom, an iodine atom and an iodine atom; a chlorine atom is preferred.
- Examples of the benzyl group include unsubstituted and substituted ones.
- the substituent includes a halogen atom and a hydroxyl group.
- the position of the substituent in the benzyl group is not particularly limited; the ⁇ -position is preferred.
- Examples of the substituted halogen atom in the benzyl group include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom; a fluorine atom and a chlorine atom are preferred.
- phenoxy groups include unsubstituted and substituted groups.
- substituents include a halogen atom and a haloalkyl group having 1 to 4 carbon atoms.
- Substituted halogen atoms in the phenoxy group include fluorine, chlorine, bromine and iodine; fluorine and chlorine are preferred.
- haloalkyl group in the phenoxy group examples include those in which the alkyl is a linear or branched alkyl group having 1 to 4 carbon atoms and has a halogen atom such as a fluorine atom, a chlorine atom, an iodine atom and an iodine atom. Although it is; Ru preferably CF 3 der.
- Examples of the tri (C 4 alkyl) silylalkoxy group include those in which the alkyl and alkoxy groups are linear or branched; preferably, the alkyl and alkoxy have carbon atoms! And more preferably 4 CH 2 S i (CH 3 ) 3 .
- alkylthio group having 1 to 4 carbon atoms examples include those having a linear or branched alkyl group; one SCH 3 is preferable.
- Examples of the pyridyl group include unsubstituted and substituted groups.
- Examples of the substituent include a halogen atom and a haloalkyl group having 1 to 4 carbon atoms.
- Examples of the substituted halogen atom in the pyridyloxy group include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom; a fluorine atom is preferred.
- Examples of the substituted haloalkyl group in the pyridyloxy group include those in which the alkyl is linear or branched having 1 to 4 carbon atoms and having a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom and an iodine atom. But preferably CF3.
- Preferred pyridyl radicals include pyridine-12-yl and pyridine-13-yl, and most preferably pyridine-12-isole.
- the position of the substituent in the pyridyloxy group is not particularly limited; however, the 3-position and the 5-position are preferred.
- alkylsulfonyl group examples include those having a linear or branched alkyl group; preferably, one is SO 2 CH 3 .
- alkylsulfinyl group there may be mentioned also have a linear or branched alkyl group; preferably an S 0 CH 3.
- alkyl is a straight-chain or
- haloalkylthio group include those in which alkyl is linear or branched having 4 to 4 carbon atoms and having a halogen atom such as a fluorine atom, a chlorine atom, an iodine atom and an iodine atom.
- Alkylcarbonyl groups include straight or branched ones having 2 to 5 carbon atoms; preferably one COCH 3 .
- the alkynyloxy group may be a straight-chain or branched one having 2 to 5 carbon atoms; preferably one OCH 2 C ⁇ CH.
- n an integer of 1 to 5, preferably 1, 2 or 3.
- M examples include alkali metals such as sodium, potassium, and cesium; potassium or cesium is preferred.
- R ′ is hydrogen atom, alkyl group having 1 to 4 carbon atoms, alkoxy group having 1 to 4 carbon atoms, halogen atom, number of haloalkyl groups having up to 4 carbon atoms, number of carbon atoms Examples thereof include 1 to 4 haloalkoxy groups and a nitro group.
- alkyl group examples include linear or branched ones having 1 to 4 carbon atoms; preferably, a methyl group and an ethyl group.
- alkoxy group examples include straight or branched ones having 1 to 4 carbon atoms; preferably, a methoxy group or an ethoxy group.
- halogen atom examples include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom; preferably, a fluorine atom and a chlorine atom.
- octaalkyl group examples include those in which the alkyl is a straight-chain or branched-chain alkyl group having 1 to 4 carbon atoms and having a halogen atom such as poly, a fluorine atom, a chlorine atom, an iodine atom and an iodine atom. it can but; is preferably an CF 3.
- haloalkoxy group examples include those in which alkoxy has a straight or branched chain having 1 to 4 atoms, and has a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom and an iodine atom. But preferably with one OCF 3 , one OCH F 2 , —OCH 2 CF 3 , —OC F 2 CH FC F 3 , one OCH FCHF 2 , —OCF 2 CH FC I and one OC B r F 2 Yes; more preferably one OCF 3 and one CH 2 CF 3 .
- R 1 examples include an alkyl group having 1 to 4 carbon atoms, a benzyl group and a phenyl group; an alkyl group having 1 to 4 carbon atoms; and an n-butyl group is more preferable.
- X is an octogen atom, and may include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom; and preferably a chlorine atom and a bromine atom.
- alkali metal fluorine compound MF examples include sodium fluoride, potassium fluoride, and cesium fluoride, with preference given to fluorinated lithium.
- phase transfer catalyst (R 1 ), ⁇ ; compound (3) include triethyl benzylammonium chloride, tetramethylammonium chloride, triethylbenzylammonium bromide, tributylbenzylammonium chloride, Trimethylbenzylammonium chloride, trimethylphenylammonium bromide, tetramethylammonium bromide, tetraethylammonium bromide, tetra-bromoammonium bromide, tetramethylammonium iodide, tetramethylammonium iodide, tetra-bromoiodide -Petit ammonium.
- the compound (1) used in the present invention is disclosed in Compound (7) and compound (12) can be produced by reacting compound (7) with compound (12) in the presence or absence of a solvent in the same manner as described in JP-A-8223.
- R, X and n are as defined above.
- the present invention relates to a method for producing a compound (1A) and a compound (2) by reacting the compound (1A) and the compound (2) in the absence of a solvent or in a solvent in the presence of a phase transfer catalyst (R 1 ) 4 NX; Can be.
- the compound (2) can be used in an amount of 1 to 10 moles per mole of the compound (1A); preferably 3 to 5 moles.
- the compound (3) can be used in an amount of 0.01 to 2 times mol of the compound (1A); preferably 0.3 to 0 times mol.
- the type of the solvent is not particularly limited as long as it does not directly participate in the reaction, and examples thereof include benzene, toluene, xylene, methylnaphthalene, petroleum ether, ligroin, hexane, chlorobenzene, dichlorobenzene, and methylene chloride. , Chlorinated or non-chlorinated aromatic, aliphatic, and lipophilic hydrocarbons, such as chloroform, dichloroethane, trichloroethylene, and cyclohexane; such as getyl ether, tetrahydrofuran, and dichlorohexane.
- DMI 1,3-dimethyl-2-imidazolidone
- the amount of the solvent to be used may be such that the amount of the compound (3) is 5 to 100% by weight; it is preferably 10 to 50% by weight.
- the reaction temperature is in the temperature range from room temperature to the boiling point of the solvent to be used, but it is preferably from 110 to 130 ° C.
- the reaction time varies depending on the concentration and temperature described above; it can be usually carried out for 2 to 5 hours.
- the target compound (1A) produced as described above is subjected to ordinary post-treatments such as extraction, concentration, filtration, etc., and, if necessary, recrystallization and various chromatographic methods. It can be appropriately purified by known means such as.
- the compound (1B) used in the present invention is obtained by dissolving the compound (14) and the compound (15) in the presence of a base in the same manner as described in JP-A-7-258223, as shown below. It can be easily produced by reacting in a medium or a solvent. '
- the compound (2) used in the present invention is the same as described above, and a commercially available product (for example, spray-dried potassium difluoride) can be used.
- a commercially available product for example, spray-dried potassium difluoride
- the target compound (4B) can be produced by reacting the compound (1B) with the compound (2) in a solvent.
- Examples of the type of the solvent include formamide, N-methylformamide, or a mixture of formamide or N-methylformamide and 1,3-dimethyl-2-imidazolidone (DMI).
- the amount of the solvent to be used may be such that the amount of the compound (1B) is 5 to 80% by weight; however, it is preferably 0 to 50% by weight.
- the compound (2) can be used in such an amount that it is used in an amount of up to 10-fold the molar amount of the compound (1B); preferably a 2- to 5-fold molar amount.
- the reaction temperature is within the temperature range from room temperature to the boiling point of the solvent used or less; preferably 50 to 10 CTC.
- reaction time varies depending on the degree of rheology and the degree of the above; it can be generally carried out for about 1 to 3 hours.
- the target compound (4B) produced as described above is subjected to ordinary post-treatments such as extraction, concentration, and oxidation, and, if necessary, recrystallization and various chromatographies. It can be appropriately purified by known means such as.
- reaction mixture was cooled to room temperature, water (20 ml) and acetic acid ethyl (20 ml) were added, and the mixture was stirred.
- the aqueous layer was extracted again with ethyl sulphate, combined with the ethyl sulphate ring, washed with water, dried over anhydrous sodium sulfate, and the ethyl sulphate was distilled off under reduced pressure, and the resulting oil was subjected to column chromatography.
- Table 1 shows the compounds synthesized as described above and their physical properties.
- Table 2 shows the compounds synthesized as described above and their physical properties.
- the mixture was heated and stirred for 1 hour.
- Table 3 shows a comparison of the production results of the compound (4) in the present invention and Comparative Examples.
- the total yield of all steps is 24.0%.
- 4,5-Dichloro-6-ethylpyrimidine (270 g) was dissolved in dichloromethane (750 ml), heated at 30 to 35, and blown with chlorine gas for 2 hours with stirring. After completion of the reaction, nitrogen gas was blown into the reaction solution to remove excessively dissolved chlorine gas. Then, dichloromethane was distilled off under reduced pressure, and the obtained oil was distilled under reduced pressure to obtain 240 g of the target substance as a pale yellow liquid.
- 2-Phenylethylamine (1.2 g) and triethylamine (1.2 g) were dissolved in toluene (30 ml), and then 4-promo 6- (1-promoethyl) -15-chloropyrimidine (3.0 g) and stirred at about 40 for 4 hours.
- Table 4 shows the compounds synthesized as described above and their physical properties.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
4-Amino-5-chloro-6-(1-fluoroethyl)pyrimidine compounds of general formula (1) useful as pest-controlling agents for agricultural and horticultural use can be prepared industrially by reacting 5-chloro-6-(1-chloroethyl)-4-(2-phenylethylamino)pyrimidine with potassium fluoride in the presence of n-tetrabutylammonium bromide, or by reacting 5-chloro-6-(1-bromoethyl)-4-(2-phenylethylamino)pyrimidine with potassium fluoride.
Description
明 細 書 Specification
4一アミノー 5—クロロー 6— (1一フル才ロェチル) ピリミジン化合物の製法 技術分野 4-Amino-5-chloro-6- (1-year-old rotyl) Pyrimidine compound manufacturing method
本発明は、 医薬 '廉薬などとして有用である 4一アミノー 5—クロロー 6— O—フル才ロェチル) ピリミジン化合物の製法に関するものであり、 更に詳し くは、 この化合物の工業的に有利な製法に関する。 背景技術 The present invention relates to a method for producing a 4-amino-5-chloro-6-O-fluroyl pyrimidine compound which is useful as a medicament or a drug, and more particularly, to an industrially advantageous method for producing this compound. About. Background art
本発明で製造する 4一アミノー 5—クロロー 6— (1一フル才ロェチル) ピリ ミジン化合物としては、 数多くの化合物が知られており、 また、 殺虫剤、 殺ダニ 剤、 ? S菌剤、 殺線虫剤などとして有用であることも知られている (例えば、 特開 平 5— 1 9 4 4 1 7号公報, 特開平 5— 2 3 0 0 3 6号公報, 特開平 6— 2 5 1 8 7号公報, 特開平 6— 1 1 6 2 4 7号公報, 特開平 6— 2 4 7 9 3 9号公報, 特開平 7— 2 5 8 2 2 3号公報及び特開平 8— 1 1 3 5 6 4号など。 ) 。 Numerous compounds are known as the 4-amino-5-chloro-6- (1-1 full-year-old rotyl) pyrimidine compound produced by the present invention, and insecticides, acaricides, and? It is also known to be useful as an S fungicide, a nematicide, etc. (for example, Japanese Patent Application Laid-Open Nos. 5-194417, 5-23036, Japanese Unexamined Patent Publication No. Hei 6—2,5187, Japanese Unexamined Patent Publication No. Hei 6-116,247, Japanese Unexamined Patent Publication No. Hei 6-247939, Japanese Unexamined Patent Publication No. Hei 7-258,223, Japanese Patent Application Laid-Open No. H08-113135, etc.).
しかしながら、 これらの先行技術の製法では、 反応工程が煩雑かつ高価な原料 を使用しなければならないこと、 反応中間体が不安定であること、 及び收率が悪 いことなどから、 工業的な製造法とは言いがたい。 However, these prior art processes require industrially complex processes because the reaction steps are complicated and expensive raw materials must be used, the reaction intermediates are unstable, and the yield is poor. It is hard to say the law.
即ち、 これらの先行技術では、 次の製法〗〜 3が知られているが、 種々の問題 点があり、 工業的に有用な方法とは言いがたい。 That is, in these prior arts, the following production methods (1) to (3) are known, but they have various problems and cannot be said to be industrially useful methods.
( 1 )製法 1 (1) Manufacturing method 1
次式 ( 5 ) The following equation (5)
で示される 4—八ロゲノー 5—クロロー 6— (1一フル才ロェチル) ピリミジン 化合物と、 次式 (6) : 4-octane-5-chloro-6- (1-one-year-old roethyl) pyrimidine compound represented by the following formula (6):
H2N-A (6) H 2 NA (6)
式中、 Aはアルキル基, ァラルキル基, シクロアルキル基などを表す, で示される種々のァミン類と反応させる方法である。 In the formula, A represents an alkyl group, an aralkyl group, a cycloalkyl group, or the like, and is a method of reacting with various amines represented by.
反応中間体である 4一ハロゲノー 5—クロロー 6— (1 一フル才ロェチル) ピ リミジン類は、 特開平 5— 1 944 1 7号公報に記載の The reaction intermediate, 4-halogeno 5-chloro-6- (1-1 full-year rotyl) pyrimidine, is disclosed in JP-A-5-194417.
(5) (Five)
式中、 Xは八ロゲン原子を表す, Where X represents an octogen atom,
に示すような方法で製造できる。 It can be manufactured by the method shown in FIG.
しかし、 この製法では、 反応工程が煩雑でありかつ高価な原料を使用しなけれ ばならないし、 また、 化合物 (5) が不安定であるという問題点がある。 However, this production method has problems that the reaction step is complicated and expensive raw materials have to be used, and that the compound (5) is unstable.
従って、 この製法は、 工業的な製造法とは言いがたい。 Therefore, this manufacturing method cannot be called an industrial manufacturing method.
(2)製法 2
次式 (8) : (2) Manufacturing method 2 The following equation (8):
式中、 Aは前記と同義である, Wherein A is as defined above,
で示される 4—アミノー 5—クロロー 6— (1一クロロェチル) ピリミジン化合 物と 4-amino-5-chloro-6- (1-chloroethyl) pyrimidine compound represented by
次式 (9) : The following equation (9):
H - R2 (9) H-R 2 (9)
式中、 R2は低級ァシル才キシ基を表す, Wherein R 2 represents a lower acyl group;
で示される低級脂肪酸類と反応させた後、 After reacting with lower fatty acids shown in
次式 ( 1 0 ) : The following equation (10):
M-OH (1 0) M-OH (10)
式中、 Mはアルカリ金属を表す, In the formula, M represents an alkali metal,
で示される無機塩基と反応させ、 さらに、 With an inorganic base represented by
次式 ( 1 1 ) : The following equation (11):
し 2H5\ 2H 5 \
— SF3 — SF 3
2H5 2H5
で示されるフッ素化剤を反応させる方法で、 目的化合物を製造することができ る。 The target compound can be produced by a method of reacting a fluorinating agent represented by
しかし、 この製法では、 反応工程が煩雑であり、 かつ高価なフッ素化剤 (化合 物 (1 1 ) ) を使用しなければならない。 However, in this production method, the reaction step is complicated, and an expensive fluorinating agent (compound (11)) must be used.
従って、 この製法も、 工業的な製造法とは言いがたい。 Therefore, this production method cannot be said to be an industrial production method.
(3)製法 3 (3) Manufacturing method 3
前記式 (8) で示される 4一アミノー 5—クロロー 6— (1一クロロェチル) ピリミジン化合物と、 次式 (1 3) :
M— F ( 1 3 ) A 4-amino-5-chloro-6- (1-chloroethyl) pyrimidine compound represented by the formula (8), and a compound represented by the following formula (13): M—F (1 3)
式中、 Mはアルカリ金厲を表す, Where M represents alkali gold ア ル カ リ
で示されるアルカリ金 フッ素化合物類とを反応させる方法により、 目的化合物 を製造することができる。 The target compound can be produced by a method of reacting with an alkali gold fluorine compound represented by the following formula.
しかし、 この製法では、 溶媒として N , N—ジメチルホルムアミド (D M F )、 N, N—ジメチルァセトアミド (D M A ) 、 1, 3—ジメチルー 2 —イミ ダゾリドン、 ジメチルスルホキシド、 スルホラン及びこれらの混合物を使用して いるが、 高い反応温度と長い反応時間を必要とし、 かつ、 収率も悪い。 However, this method uses N, N-dimethylformamide (DMF), N, N-dimethylacetamide (DMA), 1,3-dimethyl-2-imidazolidone, dimethylsulfoxide, sulfolane and mixtures thereof as solvents. However, high reaction temperature and long reaction time are required, and the yield is poor.
従って、 この製法もまた、 工業的な製造法とは言いがたい。 Therefore, this manufacturing method is also not an industrial manufacturing method.
本発明の目的は、 医薬 ·農薬として有用な 4一アミノー 5—クロロー 6— (1 一フル才ロェチル) ピリミジン化合物の工業的な製造法を提供することである。 発明の開示 An object of the present invention is to provide an industrial production method of a 4-amino-5-chloro-6- (1 -full-year-old rotyl) pyrimidine compound useful as a medicine and a pesticide. Disclosure of the invention
本発明者らは、 前記の課題を解決するために検討した結果、 4一アミノー 5— クロ口— 6— (1—フル才ロェチル) ピリミジン化合物を工業的に製造する方法 を見出し、 本発明を完成するに至った。 Means for Solving the Problems As a result of studying to solve the above problems, the present inventors have found a method for industrially producing a 4-amino-5-chloro-6- (1-full-age lotyl) pyrimidine compound. It was completed.
即ち、 本発明は次のとおりである。 That is, the present invention is as follows.
次式 (1 A ) : The following equation (1A):
式中、 Rは水素原子, 炭素数 1〜4個のアルキル基, 炭素数〗〜 4個のアル コキシ基, ハロゲン原子, 無置換又はハロゲン原子, 炭棄数〗〜 4個のアル キル基, 炭素数 1〜 4個のアルコキシ基, 炭素数 1〜 4個のハロアルキル基 の少なくとも 1つを置換基として有するベンゾィル基, 炭素数 1〜4個のハ 口アルキル基, 炭素数〗〜 4個の八口アルコキシ基, 炭素数 2〜5個のハロ
アルキルカルボニル基, 炭素数 1〜 4個のアルキルスルホニル才キシ基, 炭 素数 1 ~ 4個のハロアルキルスルホニル才キシ基, (炭素数 1〜 4個のアル コキシ基) ィミノべンジル基, 2—フエ二ルー 1 , 3—ジ才キソラニル基, 無置換又はハロゲン原子, 水酸基の少なくとも 1つを置換基として有するベ ンジル基, 無置換又はハロゲン原子, 炭素数 1〜4個のハロアルキル基の少 なくとも 1つを置換基として有するフエノキシ基, 炭素数 2〜5個のハロア ルケニルォキシ基, 炭素数 2〜 5個のアルケニルォキシ基, 卜リ (炭素数 1 ~4個のアルキル) シリルアルコキシ基, 炭素数 1 ~ 4個のアルキルチ才 基, 水酸基, 無置換又はハロゲン原子, 炭素数 1 ~4個のハロアルキル基の 少なくとも〗つを置換基として有するピリジル才キシ基, 炭素数 1 ~4個の アルキルスルホニル基, 炭素数 1 ~ 4個のアルキルスルフィニル基, 炭素数 1 ~ 4個のハロアルキルスルフィニル基, 炭素数 1〜 4個のハロアルキルチ 才基, 炭素数 1〜4個のアルキルカルボニル基, 炭素数 2〜5個のアルキニ ル才キシ基, 或いは二卜口基を表し, πは 〜 5の整数を表す, In the formula, R is a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a halogen atom, an unsubstituted or halogen atom, a carbon atom having 1 to 4 alkyl groups, An alkoxy group having 1 to 4 carbon atoms, a benzoyl group having at least one of haloalkyl groups having 1 to 4 carbon atoms as a substituent, a haloalkyl group having 1 to 4 carbon atoms, Octoalkoxy, halo with 2 to 5 carbon atoms Alkylcarbonyl group, alkylsulfonyloxy group having 1 to 4 carbon atoms, haloalkylsulfonyloxy group having 1 to 4 carbon atoms, (alkoxy group having 1 to 4 carbon atoms) iminobenzyl group, 2-phenyl At least one of a 1,3-dioxolanyl group, an unsubstituted or halogen atom, a benzyl group having at least one hydroxyl group as a substituent, an unsubstituted or halogen atom, and a haloalkyl group having 1 to 4 carbon atoms. A phenoxy group having one as a substituent, a haloalkenyloxy group having 2 to 5 carbon atoms, an alkenyloxy group having 2 to 5 carbon atoms, tri (alkyl having 1 to 4 carbon atoms) silylalkoxy group, carbon A pyridyl group having 1 to 4 alkyl groups, a hydroxyl group, an unsubstituted or halogen atom, a pyridyl group having at least one of haloalkyl groups having 1 to 4 carbon atoms as a substituent, 1 to 4 carbon atoms Alkylsulfonyl group, alkylsulfinyl group having 1 to 4 carbon atoms, haloalkylsulfinyl group having 1 to 4 carbon atoms, haloalkylthio group having 1 to 4 carbon atoms, alkylcarbonyl group having 1 to 4 carbon atoms Represents an alkynyl group having 2 to 5 carbon atoms, or a nitro group, and π represents an integer of up to 5,
で示される 4一アミノー 5—クロロー 6— (1一クロロェチル) ピリミジン化合 物と 4-Amino-5-chloro-6- (1-chloroethyl) pyrimidine compound represented by
次式 (2) : The following equation (2):
-F (2) -F (2)
式中、 Mはアルカリ金属を表す, In the formula, M represents an alkali metal,
で示されるアルカリ金属フッ素化合物類とを And alkali metal fluorine compounds represented by
次式 (3) : The following equation (3):
(R1) 4NX (3) (R 1 ) 4 NX (3)
式中、 R1は炭素数〗〜 4個のアルキル基, ベンジル基又はフエ二ル基を表 し、 Xは前記と同義である, In the formula, R 1 represents an alkyl group having 4 to 4 carbon atoms, a benzyl group or a phenyl group, and X is as defined above.
で示される第四級ァンモニゥ厶塩の存在下に反応させることを特徴とする Characterized by reacting in the presence of a quaternary ammonium salt represented by
式中、 R及び nは前記と同義である, Wherein R and n are as defined above,
で示される 4一アミノー 5—クロロー 6— (1一フルォロェチル) ピリミジン化 合物の製法に関するものである。 The present invention relates to a method for producing a 4-amino-5-chloro-6- (1-fluoroethyl) pyrimidine compound represented by the formula:
本発明は、 更に、 The invention further provides:
次式 (I B) : The following equation (I B):
式中、 R' は水素原子、 炭素原子数 1〜 4個のアルキル基、 炭素原子数 1〜 4個のアルコキシ基、 ハロゲン原子、 炭素原子数 1 ~ 4個のハロアルキル 基、 炭素原子数 1 ~4個の八口アルコキシ基及び二卜口基を表す, で示される 4一アミノー 5—クロロー (1一プロモェチル) ピリミジン化合物と 前記式 (2) : In the formula, R ′ is a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a halogen atom, a haloalkyl group having 1 to 4 carbon atoms, and a carbon atom having 1 to 4 carbon atoms. A 4-amino-5-chloro- (1-promoethyl) pyrimidine compound represented by the formula, which represents four octaalkoxy groups and a dihydroxy group, and the above formula (2):
M- F (2) M- F (2)
式中、 Mはアルカリ金属を表す, In the formula, M represents an alkali metal,
で示されるアルカリ金厲フッ素化合物とを、 ホルムアミド、 N—メチルホル厶ァ ミド、 又はホルムアミドもしくは N—メチルホルムアミドとし 3—ジメチルー 2一イミダゾリジノンとの混合物を溶媒として反応させることを特徴とする 次式 (4 B) :
(4B)
And reacting it with formaldehyde, N-methylformamide, or a mixture of formamide or N-methylformamide with 3-dimethyl-21-imidazolidinone as a solvent. Equation (4B): (4B)
式中、 R' は前記と同義である, Wherein R ′ is as defined above,
で示される 4一アミノー 5—クロロー (1一フル才ロェチル) ピリミジン化合物 の製法に関するものである。 発明を実施するための最良の形態 The present invention relates to a method for producing a 4-amino-5-chloro- (11-full-year rotyl) pyrimidine compound represented by the formula: BEST MODE FOR CARRYING OUT THE INVENTION
以下、 本発明について詳細に説明する。 Hereinafter, the present invention will be described in detail.
目的化合物である 4一アミノー 5—クロロー 6— (1一フル才ロェチル) ピリ ミジン (化合物 (4A) 及び (4 B) ) 並びにその製造原料 (化合物 (1 A) , The target compound, 4-amino-5-chloro-6- (1-fluoroethyl) pyrimidine (compounds (4A) and (4B)) and its production raw materials (compound (1A),
(1 B) , (2) 及び (3) ) で表した R, M, R1, R' 及び Xは、 次の通りで ある。 (1 B), R expressed in (2) and (3)), M, R 1, R ' and X are as follows.
(R) (R)
Rとしては、 水素原子, 炭素数 1〜4個のアルキル基, 炭素数 1〜 4個のアル コキシ基, ハロゲン原子, ベンゾィル基, 炭紊数 1〜4個のハロアルキル基, 炭 素数〗〜4個のハロアルコキシ基, 炭素数 2〜 5個のハロアルキルカルボニル 基, 炭素数 1〜 4個のアルキルスルホニル才キシ基, 炭素数〗〜 4個のハロアル キルスルホニル才キシ基, ィミノべンジル基, 2—フエ二ルー 1、 3—ジ才キソ ラニル基, ベンジル基, フエノキシ基, 炭素数 2〜 5個のハロアルケニル才キシ 基, 炭素数 2 ~ 5個のアルケニル才キシ基, 卜リ (炭素数 1〜 4個のアルキル) シリルアルコキシ基、 炭素数 1〜 4個のアルキルチ才基、 水酸基、 ピリジル才キ シ基, 炭素数〗〜 4個のアルキルスルホニル基, 炭素数 1〜 4個のアルキルスル フィニル基, 炭素数 1〜 4個のハロアルキルスルフィニル基, 炭素数〗〜 4個の ハロアルキルチ才基, '炭素数 1〜 4個のアルキルカルボニル基, 炭素数 2〜5個 のアルキニル才キシ基, ニトロ基などを挙げることができる。
Rの置換位置は、 特に限定されないが;好ましくは 2—位, 3—位及び 4一位 が好ましい。 R represents a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a halogen atom, a benzoyl group, a haloalkyl group having 1 to 4 carbon atoms, a carbon atom of 1 to 4 carbon atoms. Haloalkoxy groups, haloalkylcarbonyl groups having 2 to 5 carbon atoms, alkylsulfonyl groups having 1 to 4 carbon atoms, haloalkylsulfonyl groups having 1 to 4 carbon atoms, iminobenzyl groups, 2 —Phenyl-1,3-dioxolanyl group, benzyl group, phenoxy group, haloalkenyl group having 2 to 5 carbon atoms, alkenyl group having 2 to 5 carbon atoms, tri 1 to 4 alkyl) silylalkoxy group, C1 to C4 alkyl group, hydroxyl group, pyridyl group, C4 to C4 alkylsulfonyl group, C1 to C4 alkylsulfonyl group Finyl group, carbon number 1-4 Haloalkylsulfinyl group, haloalkyl group having 1 to 4 carbon atoms, alkylcarbonyl group having 1 to 4 carbon atoms, alkynyl group having 2 to 5 carbon atoms, nitro group, etc. . The substitution position of R is not particularly limited; however, 2-position, 3-position and 4-position are preferred.
アルキル基としては、 直鎖状又は分岐状のものを挙げることができるが;好ま しくは炭素数 1〜4個のものであり ;さらに好ましくは C H 3及び t -C 4 H 9であ る。 Examples of the alkyl group include a linear or branched alkyl group; preferably an alkyl group having 1 to 4 carbon atoms; and more preferably CH 3 and t-C 4 H 9 .
アルコキシ基としては、 直鎖状又は分岐状のものを挙げることができるが;好 ましくは炭素数 1〜 4個のものであり ;さらに好ましくは— O C H 3及び一 O C 2 H 5である。 Alkoxy groups include linear or branched ones; preferably those having 1 to 4 carbon atoms; more preferably —OCH 3 and 1 OC 2 H 5 .
ハロゲン原子としては、 フッ素原子, 塩素原子, 奥素原子及びヨウ素原子を挙 げることができるが;好ましくはフッ紊原子及び塩素原子である。 Examples of the halogen atom include a fluorine atom, a chlorine atom, an iodine atom and an iodine atom; preferred are a fluorine atom and a chlorine atom.
ベンゾィル基としては、 無置換又は置換基を有するものを挙げることができ る。 そして、 その S換基としては、 ハロゲン) ¾子, 炭素数〗〜 4個のアルキル 基, 炭素数〗〜 4個のアルコキシ基, 炭素数 1〜4個のハロアルキル基などを挙 げることができる。 Examples of the benzoyl group include unsubstituted and substituted groups. Examples of the S-substituent include a halogen) atom, an alkyl group having 4 to 4 carbon atoms, an alkoxy group having 4 to 4 carbon atoms, and a haloalkyl group having 1 to 4 carbon atoms. it can.
ベンゾィル基における置換基の位置は、 特に限定されないが; 3 _位又は 4一 位が好ましい。 The position of the substituent in the benzoyl group is not particularly limited; however, the 3_ position or the 4 position is preferable.
ベンゾィル基における置換ハロゲン原子としては、 フッ素原子, 塩素原子, 臭 素原子及びヨウ素原子を挙げることができるが;フッ素原子及び塩素原子が好ま しい。 Substituted halogen atoms in the benzoyl group include fluorine, chlorine, bromine and iodine; fluorine and chlorine are preferred.
ベンゾィル基における ϋ换アルキル基としては、 直鎖状又は分岐状のものを挙 げることができるが;好ましくは炭素数 1〜 4個のものであり ;さらに好ましく は C H 3である。 The dialkyl group in the benzoyl group may be linear or branched; preferably it has 1 to 4 carbon atoms; and more preferably CH 3 .
ベンゾィル基における置換アルコキシ基としては、 直鎖状又は分岐状のものを 挙げることができるが;好ましくは炭素数 1〜4個のものであり ;さらに好まし くは— O C H 3Tある。 Examples of the substituted alkoxy group in the benzoyl group include straight-chain or branched ones; preferably one having 1 to 4 carbon atoms; more preferably —OCH 3 T.
ベンゾィル基におけるハロアルキル基としては、 アルキルが炭素数 1 ~ 4個の
直鎖状又は分岐状であり、 フッ素原子, 塩素原子, 臭素尿子, ヨウ素原子などの ハロゲン原子を有するものを挙げることができるが;好ましくは C F 3である。 ハロアルキル基としては、 アルキルが炭素数 1〜 4個の直鎖状又は分岐状であ り、 フッ素原子, 塩素原子, 臭素原子及びヨウ素原子などのハロゲン原子を有す るものを挙げることができるが;好ましくは C F3である。 As the haloalkyl group in the benzoyl group, alkyl has 1 to 4 carbon atoms. Examples thereof include linear or branched ones having a halogen atom such as a fluorine atom, a chlorine atom, a bromine urine, and an iodine atom; preferably, CF 3 is used. Examples of the haloalkyl group include those in which alkyl is linear or branched having 1 to 4 carbon atoms and has a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom and an iodine atom. ; it is preferably CF 3.
ハロアルコキシ基としては、 アルコキシが炭素数〗〜 4個の直鎖状又は分岐状 であり、 フッ素原子, 塩素原子, 臭素原子及びヨウ素原子などのハロゲン原子を 有するものを挙げることができるが;好ましくは一 OC F3, -OCH F2, — O CH2C F3, -OC F2C H F C F3, -OCH FCH F2, — OC F2CH FC I 及び一 OC B r F2である。 Examples of the haloalkoxy group include those in which alkoxy is straight or branched having 4 to 4 carbon atoms and having a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom and an iodine atom; preferably an OC F 3, -OCH F 2, - O CH 2 CF 3, -OC F 2 CHFCF 3, -OCH FCH F 2, - a OC F 2 CH FC I and single OC B r F 2.
ハロアルキルカルボニル基としては、 アルキルが炭素数 1〜 4個の直鎖状又は 分岐状であり、 フッ素原子, 塩素原子, 臭素原子及びヨウ素原子などの八ロゲン 原子を有するものを挙げることができるが;好ましくは一 COC F3である。 アルキルスルホニル才キシ基としては、 直鎖状又は分岐状のアルキル基を有す るものを挙げることができるが;好ましくは一 OS02CH3である。 Examples of the haloalkylcarbonyl group include those in which alkyl is linear or branched having 1 to 4 carbon atoms and having an octagen atom such as a fluorine atom, a chlorine atom, a bromine atom and an iodine atom; preferably an COC F 3. Examples of the alkylsulfonyl group include those having a linear or branched alkyl group; preferably, it is OS 2 CH 3 .
ハロアルキルスルホニル才キシ基としては、 アルキルが炭素数 1〜 4個の直鎖 状又は分岐状であり、 フッ素原子, 塩素原子, 臭素原子及びヨウ素原子などのハ ロゲン原子を有するものを挙げることができるが;好ましくは一 OS02C F3で ある。 Examples of the haloalkylsulfonyloxy group include those in which the alkyl is linear or branched having 1 to 4 carbon atoms and has a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom and an iodine atom. But preferably one OS 0 2 CF 3 .
ィミノべンジル基としては、 炭素数 1〜 4個のアルコキシ基を有するものを挙 げることができる。 そして、 このアルコキシ基としては、 好ましくは一 OCH で Examples of the iminobenzyl group include those having an alkoxy group having 1 to 4 carbon atoms. And, as this alkoxy group, preferably one OCH
3ゝ ある。 There are 3 ゝ.
2—フエ二ルー 3—ジ才キソラニル基としては、 無置換又はハロゲン原子 を置換基として有するものを挙げることができる。 Examples of the 2-phenyl-3-dioxolanyl group include unsubstituted and those having a halogen atom as a substituent.
2—フエ二ルー 1, 3—ジ才キソラニル基における置換基の位置は、 特に限定 されないが;フエニル部位 4一位が好ましい。
2—フエ二ルー 1, 3—ジ才キソラニル基における置換ハロゲン原子として は、 フッ素原子、 塩素原子、 奥素原子及びヨウ素原子を挙げることができるが; 塩素原子が好ましい。 The position of the substituent in the 2-phenyl 1,3-dioxolanyl group is not particularly limited; however, the 4-position of the phenyl moiety is preferred. Examples of the substituted halogen atom in the 2-phenyl-1,3-dioxolanyl group include a fluorine atom, a chlorine atom, an iodine atom and an iodine atom; a chlorine atom is preferred.
ベンジル基としては、 無置換又は置換基を有するものを挙げることができる。 そして、 その置換基としては、 ハロゲン原子及び水酸基を挙げることができる。 ベンジル基における置換基の位置は、 特に限定されないが; α—位が好まし い。 Examples of the benzyl group include unsubstituted and substituted ones. The substituent includes a halogen atom and a hydroxyl group. The position of the substituent in the benzyl group is not particularly limited; the α-position is preferred.
ベンジル基における置換ハロゲン原子としては、 フッ素原子, 塩素原子, 臭素 原子及びヨウ素原子を挙げることができるが;フッ素原子及び塩素原子が好まし い。 Examples of the substituted halogen atom in the benzyl group include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom; a fluorine atom and a chlorine atom are preferred.
フエノキシ基としては、 無置換又は置換基を有するものを挙げることができ る。 そして、 その置換基としては、 ハロゲン原子及び炭素数〗〜 4個のハロアル キル基を挙げることができる。 Examples of phenoxy groups include unsubstituted and substituted groups. Examples of the substituent include a halogen atom and a haloalkyl group having 1 to 4 carbon atoms.
フエノキシ基における置換ハロゲン原子としては、 フッ素原子, 塩素原子, 臭 素原子及びヨウ素原子を挙げることができるが;フッ素原子及び塩素原子が好ま しい。 Substituted halogen atoms in the phenoxy group include fluorine, chlorine, bromine and iodine; fluorine and chlorine are preferred.
フエノキシ基における置换ハロアルキル基としては、 アルキルが炭素数 1〜4 個の直鎖状又は分岐状であり、 フッ素 子, 塩素原子, 奥素原子及びヨウ紊原子 などのハロゲン原子を有するものを挙げることができるが;好ましくは C F3であ る。 Examples of the haloalkyl group in the phenoxy group include those in which the alkyl is a linear or branched alkyl group having 1 to 4 carbon atoms and has a halogen atom such as a fluorine atom, a chlorine atom, an iodine atom and an iodine atom. Although it is; Ru preferably CF 3 der.
ハロアルケニル才キシ基としては、 直鎖状又は分岐状であり、 フッ素原子, 塩 素原子, 臭素原子及びヨウ素原子などのハロゲン原子を有するものを挙げること ができるが;好ましくは一 OCH-CH— CH = CH F2, -OCH2CH2C F = C F2である。 Examples of the haloalkenyl group include linear or branched groups having a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom and an iodine atom; CH = CH F 2, a -OCH 2 CH 2 CF = CF 2 .
アルケニルォキシ基としては、 直鎖状又は分岐状のものを挙げることができる が;好ましくは-OCH2CH = CH2でぁる。
トリ (炭素数 〜 4個のアルキル) シリルアルコキシ基としては、 アルキル及 びアルコキシ基が直鎖状又は分岐状のものを挙げることができるが;好ましくは アルキル及びアルコキシが炭素数!〜 4個のものであり ;さらに好ましくは一 0 C H 2 S i ( C H 3) 3である。 Alkenyloxy groups include straight-chain or branched ones; preferably -OCH 2 CH = CH 2 . Examples of the tri (C 4 alkyl) silylalkoxy group include those in which the alkyl and alkoxy groups are linear or branched; preferably, the alkyl and alkoxy have carbon atoms! And more preferably 4 CH 2 S i (CH 3 ) 3 .
炭素数〗〜 4個のアルキルチオ基としては、 直鎖状又は分岐状のアルキル基を 有するものを挙げることができるが;好ましくは一 S C H 3である。 Examples of the alkylthio group having 1 to 4 carbon atoms include those having a linear or branched alkyl group; one SCH 3 is preferable.
ピリジル才キシ基としては、 無置換又は置換基を有するものを挙げることがで きる。 そして、 その置換基としては、 ハロゲン原子及び炭素数〗〜 4個のハロア ルキル基を挙げることができる。 Examples of the pyridyl group include unsubstituted and substituted groups. Examples of the substituent include a halogen atom and a haloalkyl group having 1 to 4 carbon atoms.
ピリジルォキシ基における置換ハロゲン原子としては、 フッ素原子, 塩素原 子, 臭素原子及びヨウ素原子を挙げることができるが;好ましくはフッ素原子で ある。 Examples of the substituted halogen atom in the pyridyloxy group include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom; a fluorine atom is preferred.
ピリジルォキシ基における置換ハロアルキル基としては、 アルキルが炭素数 1 〜 4個の直鎖状又は分岐状であり、 フッ素原子, 塩素原子, 臭素原子及びヨウ素 原子などのハロゲン原子を有するものを挙げることができるが;好ましくは C F 3である。 Examples of the substituted haloalkyl group in the pyridyloxy group include those in which the alkyl is linear or branched having 1 to 4 carbon atoms and having a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom and an iodine atom. But preferably CF3.
好ましいピリジル才キシ基としては、 ピリジン一 2—ィル一才キシ, ピリジン 一 3—ィルー才キシなどを挙げることができるが;最も好ましくはピリジン一 2 一イソレー才キシである。 Preferred pyridyl radicals include pyridine-12-yl and pyridine-13-yl, and most preferably pyridine-12-isole.
ピリジルォキシ基における置換基の位置は、 特に限定されないが; 3—位及び 5—位が好ましい。 The position of the substituent in the pyridyloxy group is not particularly limited; however, the 3-position and the 5-position are preferred.
アルキルスルホニル基としては、 直鎖状又は分岐状のアルキル基を有するもの を挙げることができるが;好ましくは一 S 02 C H 3である。 Examples of the alkylsulfonyl group include those having a linear or branched alkyl group; preferably, one is SO 2 CH 3 .
アルキルスルフィニル基としては、 直鎖状又は分岐状のアルキル基を有するも のを挙げることができるが;好ましくは一 S 0 C H 3である。 The alkylsulfinyl group, there may be mentioned also have a linear or branched alkyl group; preferably an S 0 CH 3.
ハロアルキルスルフィニル基としては、 アルキルが炭素数 1〜 4個の直鎖状又 As the haloalkylsulfinyl group, alkyl is a straight-chain or
Π
は分岐状であり、 フッ素原子, 塩素原子, 奥素原子及びヨウ素原子などのハロゲ ン原子を有するものを挙げることができるが;好ましくは一 S◦ C H 2 Fである。 ハロアルキルチオ基としては、 アルキルが炭素数〗〜 4個の直鎖状又は分岐状 であり、 フッ素原子, 塩素厣子, 奥素原子及びヨウ素原子などのハロゲン原子を 有するものを挙げることができるが;好ましくは一 SCH2C F3である。 Π Is branched and includes those having a halogen atom such as a fluorine atom, a chlorine atom, an iodine atom and an iodine atom; preferably, 1 S CH 2 F. Examples of the haloalkylthio group include those in which alkyl is linear or branched having 4 to 4 carbon atoms and having a halogen atom such as a fluorine atom, a chlorine atom, an iodine atom and an iodine atom. Preferably one SCH 2 CF 3 .
アルキルカルボニル基としては、 炭素数 2〜 5個の直鎖状又は分岐状のものを 挙げることができるが;好ましくは一 COCH3である。 Alkylcarbonyl groups include straight or branched ones having 2 to 5 carbon atoms; preferably one COCH 3 .
アルキニルォキシ基としては、 炭素数 2〜 5個の直鎖状又は分岐状のものを挙 げることができるが;好ましくは一 OCH2C≡CHである。 The alkynyloxy group may be a straight-chain or branched one having 2 to 5 carbon atoms; preferably one OCH 2 C≡CH.
(n) (n)
nは 1〜 5の整数を表すが; 1, 2又は 3が好ましい。 n represents an integer of 1 to 5, preferably 1, 2 or 3.
(*) (*)
*は不斉炭素原子を表す。 * Represents an asymmetric carbon atom.
(M) (M)
Mとしては、 ナトリウム, カリウム, セシウムなどのアルカリ金属が挙げられ るが;力リゥ厶又はセシウムが好ましい。 Examples of M include alkali metals such as sodium, potassium, and cesium; potassium or cesium is preferred.
(R, ) (R,)
R' としては、 水素厥子、 炭素原子数 1〜 4個のアルキル基、 炭素原子数 1〜 4個のアルコキシ基、 ハロゲン原子、 炭紊屎子数 〜 4個のハロアルキル基、 炭 素原子数 1〜 4個のハロアルコキシ基、 二卜口基を挙げることができる。 R ′ is hydrogen atom, alkyl group having 1 to 4 carbon atoms, alkoxy group having 1 to 4 carbon atoms, halogen atom, number of haloalkyl groups having up to 4 carbon atoms, number of carbon atoms Examples thereof include 1 to 4 haloalkoxy groups and a nitro group.
アルキル基としては、 直鎖状又は分岐状の炭素原子数 1〜 4個のものを挙げる ことができるが;好ましくは、 メチル基, ェチル基である。 Examples of the alkyl group include linear or branched ones having 1 to 4 carbon atoms; preferably, a methyl group and an ethyl group.
アルコキシ基としては直鎖状又は分岐状の炭素原子数 1〜 4個のものを挙げる ことができるが;好ましくは、 メ卜キシ基, ェ卜キシ基である。 Examples of the alkoxy group include straight or branched ones having 1 to 4 carbon atoms; preferably, a methoxy group or an ethoxy group.
ハロゲン原子としては、 フッ素原子、 塩素原子、 臭素原子及びヨウ素原子など を挙げることができるが;好ましくは、 フッ素原子、 塩素原子である。
八口アルキル基としては、 アルキルが直鎖状又は分岐状の炭素原子数 1〜4個 のものでぁリ、 フッ素原子、 塩素原子、 奧素原子及びヨウ素原子などのハロゲン 原子を有するものを挙げることができるが;好ましくは一 C F3である。 Examples of the halogen atom include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom; preferably, a fluorine atom and a chlorine atom. Examples of the octaalkyl group include those in which the alkyl is a straight-chain or branched-chain alkyl group having 1 to 4 carbon atoms and having a halogen atom such as poly, a fluorine atom, a chlorine atom, an iodine atom and an iodine atom. it can but; is preferably an CF 3.
ハロアルコキシ基としては、 アルコキシが直鎖状又は分岐状の炭紊原子数 1 ~ 4個のものであり、 フッ素原子、 塩素原子、 臭素原子及びヨウ素原子などのハロ ゲン原子を有するものを挙げることができるが;好ましくは一 OC F3, 一 OCH F2, —OCH2CF3, -OC F2C H FC F3, 一 OCH FCHF2, — OCF2C H FC I及び一 OC B r F2であり ;さらに好ましくは一 O C F 3及び一 0 C H 2 C F3である。 Examples of the haloalkoxy group include those in which alkoxy has a straight or branched chain having 1 to 4 atoms, and has a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom and an iodine atom. But preferably with one OCF 3 , one OCH F 2 , —OCH 2 CF 3 , —OC F 2 CH FC F 3 , one OCH FCHF 2 , —OCF 2 CH FC I and one OC B r F 2 Yes; more preferably one OCF 3 and one CH 2 CF 3 .
(R,) (R,)
R1としては、 炭素数 1〜 4個のアルキル基、 ベンジル基又はフエニル基が挙げ られるが;炭素数〗〜 4個のアルキル基;さらに n-プチル基が好ましい。 Examples of R 1 include an alkyl group having 1 to 4 carbon atoms, a benzyl group and a phenyl group; an alkyl group having 1 to 4 carbon atoms; and an n-butyl group is more preferable.
(X) (X)
Xは、 八ロゲン原子であり、 フッ素原子、 塩素原子、 臭素原子及びヨウ素原子 などを挙げることができるが;好ましくは、 塩素原子及び臭素原子である。 X is an octogen atom, and may include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom; and preferably a chlorine atom and a bromine atom.
アルカリ金属フッ素化合物 M— F ;化合物 (2) の具体的な例としては、 フッ ィ匕ナトリウム、 フッ化カリウム、 フッ化セシウムなどが挙げられるが、 フッ化力 リウ厶が好ましい。 Specific examples of alkali metal fluorine compound MF; compound (2) include sodium fluoride, potassium fluoride, and cesium fluoride, with preference given to fluorinated lithium.
相間移動触媒 (R1) ,ΝΧ;化合物 (3) の具体的な例として、 塩化トリェチ ルペンジルアンモニゥ厶, 塩化テトラメチルアンモニゥム, 臭化卜リエチルベン ジルアンモニゥ厶, 塩化トリブチルベンジルアンモニゥ厶, 塩化トリメチルベン ジルアンモニゥ厶, 臭化卜リメチルフエ二ルアンモニゥ厶, 臭化テ卜ラメチルァ ンモニゥム, 臭化テトラェチルアンモニゥ厶, 臭化テトラー η-プチルアンモニ ゥ厶, ヨウ化テ卜ラメチルンモニゥ厶, ヨウ化テトラー η-プチルアンモニゥ厶 などが挙げられる。 Specific examples of the phase transfer catalyst (R 1 ), ΝΧ; compound (3) include triethyl benzylammonium chloride, tetramethylammonium chloride, triethylbenzylammonium bromide, tributylbenzylammonium chloride, Trimethylbenzylammonium chloride, trimethylphenylammonium bromide, tetramethylammonium bromide, tetraethylammonium bromide, tetra-bromoammonium bromide, tetramethylammonium iodide, tetramethylammonium iodide, tetra-bromoiodide -Petit ammonium.
本発明において使用する化合物 (1 Α) は、 次に示すように、 特開平 7— 25
8223号公報に記載と同様に化合物 (7) と化合物 (1 2) を塩基の存在下に 無溶媒又は溶媒中で反応させることによつて製造することができる。 The compound (1) used in the present invention is disclosed in Compound (7) and compound (12) can be produced by reacting compound (7) with compound (12) in the presence or absence of a solvent in the same manner as described in JP-A-8223.
式中、 R, X及び nは前記と同義である。 In the formula, R, X and n are as defined above.
本発明で使用する化合物 (2) 及び化合物 (3) は、 市販品を好適に使用する ことができる。 As the compound (2) and the compound (3) used in the present invention, commercially available products can be suitably used.
本発明は、 化合物 (1 A) と化合物 (2) とを相間移動触媒 (R1) 4NX;化 合物 (3) の存在下に無溶媒又は溶媒中で反^させることによって製造すること ができる。 The present invention relates to a method for producing a compound (1A) and a compound (2) by reacting the compound (1A) and the compound (2) in the absence of a solvent or in a solvent in the presence of a phase transfer catalyst (R 1 ) 4 NX; Can be.
化合物 (2) の使用量は、 化合物 (1 A) に対して 1〜1 0倍モルになるよう にして使用することができるが; 3〜 5倍モルが好ましい。 The compound (2) can be used in an amount of 1 to 10 moles per mole of the compound (1A); preferably 3 to 5 moles.
化合物 (3) の使用量は、 化合物 (1 A) に対して 0. 0 1 ~ 2倍モルになる ようにして使用することができるが; 0. 3〜 0倍モルが好ましい。 The compound (3) can be used in an amount of 0.01 to 2 times mol of the compound (1A); preferably 0.3 to 0 times mol.
溶媒の種類としては、 本反応に直接関与しないものであれば特に限定されず、 例えば、 ベンゼン, トルエン, キシレン, メチルナフタリン, 石油エーテル, リ グロイン, へキサン, クロルベンゼン, ジクロルベンゼン, 塩化メチレン, クロ 口ホルム, ジクロルェタン, トリクロルエチレン, シクロへキサンのような塩素 化された又はされていない芳香族, 脂肪族, 脂瑋式の炭化水素類;ジェチルエー テル, テ卜ラヒドロフラン, ジ才キサンなどのようなエーテル類;ァセ卜ニ卜リ
ル, プロピオ二卜リルなどのような二卜リル類; N, N—ジメチルホルムアミド (DMF) , N, N—ジメチルァセトアミド, 1, 3—ジメチルー 2—^ Γミダゾ リドン (DM I ) のようなアミド類;ジメチルスルホキサイド及び前記溶媒の混 合物などを挙げることができるが; N, N—ジメチルホルムアミド (DMF) 、The type of the solvent is not particularly limited as long as it does not directly participate in the reaction, and examples thereof include benzene, toluene, xylene, methylnaphthalene, petroleum ether, ligroin, hexane, chlorobenzene, dichlorobenzene, and methylene chloride. , Chlorinated or non-chlorinated aromatic, aliphatic, and lipophilic hydrocarbons, such as chloroform, dichloroethane, trichloroethylene, and cyclohexane; such as getyl ether, tetrahydrofuran, and dichlorohexane. Ethers; acetate N, N-dimethylformamide (DMF), N, N-dimethylacetamide, 1,3-dimethyl-2-^^ midazolidone (DMI) Amides such as dimethyl sulfoxide and a mixture of the above-mentioned solvents; and N, N-dimethylformamide (DMF);
1 , 3—ジメチルー 2—イミダゾリドン (DM I ) のようなアミド類が好まし い。 Amides such as 1,3-dimethyl-2-imidazolidone (DMI) are preferred.
溶媒の使用量は、 化合物 (3) が 5~1 00重量%になるようにして使用する ことができるが; 1 0〜50重量 が好ましい。 The amount of the solvent to be used may be such that the amount of the compound (3) is 5 to 100% by weight; it is preferably 10 to 50% by weight.
反応温度は、 室温から使用する溶媒の沸点以下の温度範囲内であるが; 1 1 0 ~ 1 30°Cが好ましい。 The reaction temperature is in the temperature range from room temperature to the boiling point of the solvent to be used, but it is preferably from 110 to 130 ° C.
反応時間は、 前記の濃度, 温度によって変化するが;通常 2〜 5時間で行うこ とができる。 The reaction time varies depending on the concentration and temperature described above; it can be usually carried out for 2 to 5 hours.
以上のようにして製造された目的の化合物 (1 A) は、 反応終了後、 抽出, 濃 縮, 溏過などの通常の後処理を行い、 必要に応じて再結晶, 各種クロマ卜グラフ ィーなどの公知の手段で適宜精製することができる。 After completion of the reaction, the target compound (1A) produced as described above is subjected to ordinary post-treatments such as extraction, concentration, filtration, etc., and, if necessary, recrystallization and various chromatographic methods. It can be appropriately purified by known means such as.
本発明で使用する化合物 (1 B) は、 次に示すように、 特開平 7— 25822 3号公報に記載と同様に化合物 (1 4) と化合物 (1 5) を塩基の存在下に無溶 媒又は溶媒中で反応させることによって容易に製造することができる。 ' The compound (1B) used in the present invention is obtained by dissolving the compound (14) and the compound (15) in the presence of a base in the same manner as described in JP-A-7-258223, as shown below. It can be easily produced by reacting in a medium or a solvent. '
化合物 (1 B) としては、 例えば、 後述の参考例に示した方法で合成した表 3 に示すようなものを挙げることができる。 As the compound (1B), for example, the compound shown in Table 3 synthesized by the method shown in the below-mentioned reference example can be mentioned.
本発明で使用する化合物 (2) は、 前記と同様であり、 市販品 (例えば、 スプ レードライ■フッ化カリウム) を使用することができる。 The compound (2) used in the present invention is the same as described above, and a commercially available product (for example, spray-dried potassium difluoride) can be used.
本発明では、 目的化合物 (4 B) は、 化合物 (1 B) と化合物 (2) とを溶媒 中で反応させることによって製造することができる。 In the present invention, the target compound (4B) can be produced by reacting the compound (1B) with the compound (2) in a solvent.
溶媒の種類としては、 ホルムアミド、 N—メチルホルムアミド、 又はホル厶ァ ミドもしくは N—メチルホルムアミドと 1 , 3—ジメチルー 2—イミダゾリドン (DM I ) との混合物を挙げることができる。 Examples of the type of the solvent include formamide, N-methylformamide, or a mixture of formamide or N-methylformamide and 1,3-dimethyl-2-imidazolidone (DMI).
溶媒の使用量は、 化合物 (1 B) が 5〜80重量%になるようにして使用する ことができるが; 〗 0〜50重量%が好ましい。 The amount of the solvent to be used may be such that the amount of the compound (1B) is 5 to 80% by weight; however, it is preferably 0 to 50% by weight.
化合物 (2) の使用量は、 化合物 (1 B) に対して 〜 1 0倍モルになるよう にして使用することができるが; 2〜5倍モルが好ましい。 The compound (2) can be used in such an amount that it is used in an amount of up to 10-fold the molar amount of the compound (1B); preferably a 2- to 5-fold molar amount.
反応温度は、 室温から使用する溶媒の沸点以下の温度範囲内であるが; 50〜 1 0 CTCが好ましい。 The reaction temperature is within the temperature range from room temperature to the boiling point of the solvent used or less; preferably 50 to 10 CTC.
反応時間は, 前記の濂度, 溫度によって変化するが;通常〗〜 3時間で行うこ とができる。 The reaction time varies depending on the degree of rheology and the degree of the above; it can be generally carried out for about 1 to 3 hours.
以上のようにして製造された目的の化合物 (4 B) は、 反応終了後、 抽出, 濃 縮, 澳過などの通常の後処理を行い、 必要に応じて再結晶, 各種クロマ卜グラフ ィーなどの公知の手段で適宜精製することができる。 実施例 After completion of the reaction, the target compound (4B) produced as described above is subjected to ordinary post-treatments such as extraction, concentration, and oxidation, and, if necessary, recrystallization and various chromatographies. It can be appropriately purified by known means such as. Example
以下、 本発明を実施例によって具体的に説明する。 なお、 これらの実施例は、 本発明の範囲を限定するものではない。 Hereinafter, the present invention will be described specifically with reference to Examples. Note that these examples do not limit the scope of the present invention.
実施例 1 (化合物 (4) の合成)
(1) 5—クロロー 6— (1一フル才ロェチル) 一 4一 (2—フエニルェチルアミ ノ) ピリミジン (化合物 1 ) の合成 Example 1 (Synthesis of Compound (4)) (1) Synthesis of 5-chloro-6- (1-year-old roethyl) 1-41- (2-phenylethylamino) pyrimidine (compound 1)
臭化テ卜ラー n-プチルアンモニゥ厶 (2. 7 g) とスプレードライのフッ化 カリウム (3. 9 g) を 1 1 5°C〜1 2 CTCに加溫、 攒拌、 良く練り合わせる。 この状態で、 5—クロロー 6— (1一クロロェチル) 一 4一 (2—フエニルェ チルァミノ) ピリミジン (5. 0 g) を添加し、 同温度で 2時間攪拌する。 反応終了後、 水 (30m l ) を加え、 齚酸ェチルで抽出した。 抽出液を水洗、 無水硫酸ナトリウムで乾燥後、 減圧下に舴酸ェチルを留去し、 得られた油状物を カラムクロマトグラフィー (ヮコ一ゲル C一 200、 トルエン:酢酸ェチル = 9 : 1溶出) によって無色粉状結晶である目的物を 3. 0 g (6 3. 7 %) 得 た。 Heat n-butylammonium bromide (2.7 g) and spray-dried potassium fluoride (3.9 g) to 115 ° C to 12 CTC, stir, and knead well. In this state, add 5-chloro-6- (1-chloroethyl) -141- (2-phenylethylamino) pyrimidine (5.0 g) and stir at the same temperature for 2 hours. After completion of the reaction, water (30 ml) was added, and the mixture was extracted with ethyl acetate. The extract was washed with water and dried over anhydrous sodium sulfate, and ethyl acetate was distilled off under reduced pressure. The resulting oil was purified by column chromatography (Co-gel C-200, toluene: ethyl acetate = 9: 1 elution). ) To give 3.0 g (63.7%) of the target product as colorless powdery crystals.
(2)化合物 1の合成 (2) Synthesis of compound 1
5—クロ口一 6— (1一クロロェチル) 一 4一 (2—フエニルェチルァミノ) ピリミジン (5. 0 g) を無水の 1, 3—ジメチルー 2—イミダゾリドン (8 m I ) に加温溶解し、 臭化テトラー n-プチルアンモニゥ厶 (2. 1 g) とスプレ 一ドライのフッ化カリウム (3. 0 g) を加え、 1 1 0°C〜1 1 5°Cで 4時間攪 拌反応した。 Add 5- (1-chloroethyl) 1-4-1 (2-phenylethylamino) pyrimidine (5.0 g) to anhydrous 1,3-dimethyl-2-imidazolidone (8 ml). Dissolve in water, add tetra-n-butylammonium bromide (2.1 g) and spray-dried potassium fluoride (3.0 g), and stir at 110 ° C to 115 ° C for 4 hours. Reacted.
反応終了後、 室温まで冷却し水 (30m l ) と St酸ェチル (30m l ) を加え 授拌した後、 酢酸ェチル層を分取した。 水層を ft酸ェチルで 1度抽出し、 先の醉 酸ェチル層に併せ水洗、 無水硫酸ナ卜リウ厶で乾燥後、 減圧下に酢酸ェチルを留 去し、 得られた油状物をカラムクロマトグラフィー (ヮコ一ゲル C一 20 0、 卜 ルェン:6ΐ酸ェチル = 9 : 1溶出) によって無色粉状結晶である目的物を 3. 3 g (7 0. 0%) 得た。 After completion of the reaction, the mixture was cooled to room temperature, water (30 ml) and St-ethyl (30 ml) were added, and the mixture was stirred, and then the ethyl acetate layer was separated. The aqueous layer was extracted once with ethyl acetate, washed with the ethyl acetate layer, dried over anhydrous sodium sulfate, and then ethyl acetate was distilled off under reduced pressure.The resulting oil was subjected to column chromatography. 3.3 g (70.0%) of the desired product as colorless powdery crystals was obtained by chromatography (ヮ -gel C-200, elution with toluene: ethyl 6ΐ = 9: 1).
(3) 5—クロロー 6— (1—フル才ロェチル) 一 4一 〔2— (4一メチルフエ二 ル) ェチルァミノ〕 ピリミジン (化合物 2) の合成 (3) Synthesis of 5-chloro-6- (1-furethyl) -141 [2- (4-methylphenyl) ethylamino] pyrimidine (Compound 2)
5—クロロー 6— (1一クロロェチル) 一 4一 〔2— (4一メチルフエニル)
ェチルァミノ〕 ビリミジン (3. 1 g) を無水の 1 , 3—ジメチルー 2—イミダ ゾリドン (5m l ) に加温溶解し、 奧化テ卜ラー n-プチルアンモニゥ厶 (1. 3 g) とスプレードライのフッ化カリウム (1. 8 g) を加え、 1 1 0 〜 1 1 5でで 4時間撹拌反応した。 5-chloro-6- (1-chloroethyl) 1-41 [2- (4-methylphenyl) Ethilamino] Bilimidine (3.1 g) was dissolved in anhydrous 1,3-dimethyl-2-imidazolidone (5 ml) by heating, and the solution was sprayed on an Oka Tetra n-butylammonium (1.3 g) and spray-dried. Potassium fluoride (1.8 g) was added, and the mixture was stirred and reacted at 110 to 115 for 4 hours.
反応終了後、 室温まで冷却し水 (20m l ) と酢酸ェチル (20m l ) を加え 攪拌した後、 酢酸ェチル層を分取した。 水 «を酢酸ェチルで再度抽出し、 先の齚 酸ェチル層に併せ水洗、 無水硫酸ナトリウムで乾燥後、 減圧下に ft酸ェチルを留 去し、 得られた油状物をカラムクロマトグラフィー (ヮコ一ゲル C— 200、 卜 ルェン:酢酸ェチル =9 : 1溶出) によって無色粉状結晶である目的物を 2. 0 g (68. 1 %) 得た。 After completion of the reaction, the mixture was cooled to room temperature, water (20 ml) and ethyl acetate (20 ml) were added, and the mixture was stirred, and the ethyl acetate layer was separated. The water was extracted again with ethyl acetate, combined with the previous ethyl acetate layer, washed with water, dried over anhydrous sodium sulfate, and ft-ethyl acetate was distilled off under reduced pressure. The resulting oil was purified by column chromatography (ヮ CO One gel C-200, elution with toluene: ethyl acetate = 9: 1) yielded 2.0 g (68.1%) of the target compound as colorless powdery crystals.
(4) 5—クロロー 6— (1一フル才ロェチル) —4- 〔2— (4ーメ卜キシフエ ニル) ェチルァミノ〕 ピリミジン (化合物 3) の合成 (4) Synthesis of 5-chloro-6- (1 -year-old rotyl) -4- [2- (4-methoxyphenyl) ethylamino] pyrimidine (Compound 3)
5—クロロー 6— (1一クロロェチル) 一 4一 〔2— (4ーメ卜キシフエ二 ル) ェチルァミノ〕 ピリミジン (3. 3g) を無水の N, N—ジメチル木ル厶ァ ミド (5m l ) に加温溶解し、 臭化テトラー n-プチルアンモニゥ厶 (1. 3 g) とスプレードライのフッ化カリウム (1. 8 g) を加え、 1 1 0°C〜1 1 5 で 4時間擾拌反応した。 5-Chloro-6- (1-Chloroethyl) 1-41 [2- (4-Methoxyphenyl) ethylamino] Pyrimidine (3.3 g) is converted to anhydrous N, N-dimethyl-wood lumamide (5 ml) Then, add tetra-n-butylammonium bromide (1.3 g) and spray-dried potassium fluoride (1.8 g), and stir at 110 ° C to 115 for 4 hours. did.
反応終了後、 室溫まで冷却し水 (20m l ) と 酸ェチル (20m l ) を加え 擾拌した後、 酢酸ェチル層を分取した。 水層を酔酸ェチルで再度抽出し、 先の齚 酸ェチル環に併せ水洗、 無水硫酸ナ卜リウ厶で乾燥後、 減圧下に醉酸ェチルを留 去し、 得られた油状物をカラムクロマトグラフィー (ヮコ一ゲル C一 200、 卜 ルェン:酔酸ェチル =9 : 1溶出) によって無色粉状結晶である目的物を 2. 0 g (64. 6 %) 得た。 After the completion of the reaction, the reaction mixture was cooled to room temperature, water (20 ml) and acetic acid ethyl (20 ml) were added, and the mixture was stirred. The aqueous layer was extracted again with ethyl sulphate, combined with the ethyl sulphate ring, washed with water, dried over anhydrous sodium sulfate, and the ethyl sulphate was distilled off under reduced pressure, and the resulting oil was subjected to column chromatography. By chromatography (グ ラ フ ィ ー -gel C-200, elution with toluene: ethyl ethyl acetate = 9: 1), 2.0 g (64.6%) of the target compound as colorless powdery crystals was obtained.
(5) 5—クロロー 6— (1—フル才ロェチル) 一 4一 〔2— 〔4一 (卜リフル才 ロメ卜キシ) フエニル〕 ェチルァミノ〕 ピリミジン (化合物 1 4) の合成 (5) Synthesis of 5-chloro-6- (1-flurocetyl) 1-41 [2- [4-1 (triflume-l-methoxy) phenyl] ethylamino] pyrimidine (compound 14)
5—クロロー 6— (1—クロロェチル) 一 4一 (2— 〔4一トリフル才ロメ卜
キシ) フエニル〕 ェチルァミノ〕 ピリミジン (20. 0 g) を無水の 3—ジ メチルー 2—イミダゾリドン (20m l ) に加温溶解し、 臭化テトラ- n-ブチル アンモニゥ厶 (8. 6 g) とスプレードライのフッ化カリウム (1 2. 2 g) を 加え、 1 1 0で〜 1 1 5でで 4時間攪袢反^した。 5—Chloro 6— (1—Chloroethyl) 1 4 1 (2— [4 1 Xy) phenyl] ethylamino] pyrimidine (20.0 g) is dissolved in anhydrous 3-dimethyl-2-imidazolidone (20 ml) by heating, and sprayed with tetra-n-butylammonium bromide (8.6 g) Dry potassium fluoride (12.2 g) was added, and the mixture was stirred at 110 to 115 for 4 hours.
反応終了後、 室温まで冷却し水 (20m l ) と酢酸ェチル (20m を加え 攪拌した後、 酢酸ェチル層を分取した。 水層を酢酸ェチルで再度抽出し、 先の酢 酸ェチル層に併せ水洗、 無水硫酸ナ卜リウ厶で乾燥後、 減圧下に酢酸ェチルを留 去し、 得られた油状物をカラムクロマトグラフィー (ヮコ一ゲル C— 200、 卜 ルェン:酢酸ェチル =9 : 1溶出) によって無色粉状結晶である目的物を 1 4. 0 g (73. 2 %) 得た。 After the reaction was completed, the reaction mixture was cooled to room temperature, added with water (20 ml) and ethyl acetate (20 ml), stirred, and the ethyl acetate layer was separated. The aqueous layer was extracted again with ethyl acetate and combined with the previous ethyl acetate layer. After washing with water and drying over anhydrous sodium sulfate, ethyl acetate is distilled off under reduced pressure, and the resulting oil is subjected to column chromatography (ヮ -gel C-200, toluene: ethyl acetate = 9: 1 elution). The above yielded 14.0 g (73.2%) of the desired product as colorless powdery crystals.
(6)表 1中の化合物 (4) の合成 (6) Synthesis of compound (4) in Table 1
前記の 0)〜(5)に記載の方法に準じて、 表 1中のその他の化合物 (4) を合成 した。 Other compounds (4) in Table 1 were synthesized according to the methods described in the above (0) to (5).
以上のようにして合成した化合物及びその物性を表 1に示す。
Table 1 shows the compounds synthesized as described above and their physical properties.
さらに、 'Η— NMR (CDC I 3) <5 p pmについては、 次の通りである。 (化合物 1 ) Further, for 'Η-NMR (CDC I 3 ) <5 ppm, it is as follows. (Compound 1)
1. 59〜1. 72 (d-d, 3 H) , 2. 84〜 2. 95 ( t , 2 H) , 3. 7 "!〜 3. 79 (q, 2 H) , 5. 48〜 5, 60 (m, 1 H) , 5. 73 〜6. 01 (m, 1 H) , 7. 1 1 ~7. 36 (m, 5 H) , 8. 52 (s, 1 H) 1.59 to 1.72 (dd, 3H), 2.84 to 2.95 (t, 2H), 3.7 "! To 3.79 (q, 2H), 5.48 to 5, 60 (m, 1 H), 5.73 to 6.01 (m, 1 H), 7.1 1 to 7.36 (m, 5 H), 8.52 (s, 1 H)
(化合物 1 4) (Compound 14)
1. 62~1. 73 (d-d, 3 H) , 2. 92~3. 01 (t, 2 H) , 3. 76〜 3. 85 (m, 2 H) , 5. 46〜 5. 62 (m, 1 H) , 5. 78 ~6. 04 (d-q , 1 H) , 7. 1 1〜7. 20 (d , 2 H) , 7. 22〜 7. 28 (d, 2 H) , 8. 59 (s, 1 H) 1.62 ~ 1.73 (dd, 3 H), 2.92 ~ 3.01 (t, 2 H), 3.76 ~ 3.85 (m, 2 H), 5.46 ~ 5.62 ( m, 1 H), 5.78 to 6.04 (dq, 1 H), 7.1 1 to 7.20 (d, 2 H), 7.22 to 7.28 (d, 2 H), 8 . 59 (s, 1 H)
(化合物 36 ) (Compound 36)
1. 60〜1. 73 (d-d, 3 H) , 2. 73 (s, 3 H) , 3. 00〜 3. 05 (m, 2H) , 3. 81〜 3. 84 (m, 2 H) , 5. 48〜 5. 65 (m, 1 H) , 5. 81〜5. 96 (d-q, 2 H) , 7. 38〜7. 4 1 (d, 2 H) , 7. 60〜 7. 63 (d, 2 H) , 8. 56 (s, 1 H) 実施例 2 (化合物 (4 B) の合成) 1.60 to 1.73 (dd, 3H), 2.73 (s, 3H), 3.00 to 3.05 (m, 2H), 3.81 to 3.84 (m, 2H) , 5.48 to 5.65 (m, 1 H), 5.81 to 5.96 (dq, 2 H), 7.38 to 7.41 (d, 2 H), 7.60 to 7. 63 (d, 2 H), 8.56 (s, 1 H) Example 2 (Synthesis of Compound (4B))
(1) (土) 5—クロ口— 6— (1一フル才ロェチル) 一 4一 (2—フエニルェチル ァミノ) ピリミジン (化合物 1 ) の合成 (1) (Sat) 5-—Mouth—6 -— (1—one-year-old roetil) 1-41 (2-Phenylethyl amino) Synthesis of pyrimidine (Compound 1)
6— (1ーブロモェチル) 一 5—クロロー 4一 (2—フエニルェチルァミノ) ピリミジン (1. 0 g) をホルムアミド (2m I ) と 1, 3—ジメチルー 2—ィ ミダゾリジノン (DM I ) (2m l ) の混合溶媒に溶解し、 スプレードライの フッ化カリウム (0. 5 g) を加え、 油浴中 80でで 3時間攬拌した。 6- (1-Bromoethyl) -1-5-chloro-4-1 (2-phenylethylamino) pyrimidine (1.0 g) was added to formamide (2mI) and 1,3-dimethyl-2-imidazolidinone (DMI) (DMI) ( 2 ml), mixed with spray-dried potassium fluoride (0.5 g), and stirred in an oil bath at 80 for 3 hours.
反応終了後、 水 (1 Om I ) を加え, 酢酸ェチルで抽出し、 水洗、 無水 ¾£酸ナ トリウムで乾燥した。 After completion of the reaction, water (1 OmI) was added, extracted with ethyl acetate, washed with water, and dried over anhydrous sodium sulfate.
減圧下に酢酸ェチルを留去し、 得られた油状物をカラムクロマトグラフィー
(ヮコーケソレ C一 200、 トルエン:酔酸ェチル =2 0 : 1〜5 : 1溶出) に よって無色粉状態結晶である目的物を 0. 5 6 g (6 8. 3 %) 得た。 Ethyl acetate was distilled off under reduced pressure, and the obtained oil was purified by column chromatography. (ヮ Kokesole C-200, toluene: ethyl ethyl sulphate = 20: 1 to 5: 1 elution) gave 0.56 g (68.3%) of the target compound as colorless powdery crystals.
• 1 H - NM R (CDC I 3) <5 p pm • 1 H-NMR (CDC I 3 ) <5 p pm
2. 00〜 2. 02 (q , 3 H) , 2. 9 2〜 2. 9 7 ( t, 2 H) , 2.00 to 2.02 (q, 3H), 2.92 to 2.97 (t, 2H),
3. 7 5〜 3. 8 2 (q, 2 H) , 5. 38〜 5. 4 5 (q, 1 H) , 3.75 to 3.82 (q, 2H), 5.38 to 5.45 (q, 1H),
5. 5 5 (s, 1 H) , 7. 2 2~7. 3 6 (m, 5 H) , 5.5 5 (s, 1 H), 7.2 2 to 7.36 (m, 5 H),
8. 54 (s, 1 H) 8.54 (s, 1 H)
(2) (士) 5—クロロー 6— (1一フルォロェチル) 一 4一 [2— (4—メチルフ ェニル) ェチルァミノ] ピリミジン (化合物 2) の合成 (2) (Ch) Synthesis of 5-chloro-6- (1-fluoroethyl) 1-41- [2- (4-methylphenyl) ethylamino] pyrimidine (Compound 2)
6— (1一プロモェチル) 一 5—クロロー 4一 [2— (4—メチルフエニルェ チルァミノ) ピリミジン (1 · 0 g) をホルムアミド (2m l ) と 1, 3—ジメ チルー 2—イミダゾリジノン (DM I ) (2m I ) の混合溶媒に溶解し、 スプレ 一ドライのフッ化カリウム (0. 5 g) を加え、 油浴中 80。Cで 3時間撹拌し た。 6— (1-Promoethyl) 1-5-Chloro4-1- [2- (4-Methylphenylethylamino) pyrimidine (1.0 g) is added to formamide (2 ml) and 1,3-dimethyl-2-imidazolidinone (DM I ) Dissolve in the mixed solvent of (2mI), add spray-dried potassium fluoride (0.5 g), and in an oil bath. The mixture was stirred at C for 3 hours.
反応終了後、 水 (1 Om I ) を加え, 齚酸ェチルで抽出し、 水洗、 無水硫酸ナ 卜リウ厶で乾燥した。 減圧下に齚酸ェチルを留去し、 得られた油状物をカラ厶ク ロマトグラフィー (ヮコ一ゲル C— 2 00、 トルエン:酢酸ェチル =20 : ■!〜 5 : 1溶出) によって無色粉状態結晶である目的物を 0. 5 8 g (7 0. 0%) 得た。 After completion of the reaction, water (1 OmI) was added, extracted with ethyl acetate, washed with water, and dried over anhydrous sodium sulfate. The ethyl acetate was distilled off under reduced pressure, and the obtained oil was purified by column chromatography (co-gel C—200, toluene: ethyl acetate = 20: ■! To 5: 1 elution) to give a colorless powder. 0.58 g (70.0%) of the desired product as a state crystal was obtained.
(3) (土) 5—クロロー 6— (1一フル才ロェチル) 一 4一 [2— (4ーメトキシ フエニル) ェチルァミノ] ピリミジン (化合物 3) の合成 (3) (Sat) Synthesis of 5-chloro-6- (1-full-year roethyl) 1-41- [2- (4-methoxyphenyl) ethylamino] pyrimidine (Compound 3)
6— (1一プロモェチル) 一 5—クロロー 4一 [2— (4一メ卜キフエニルェ チルァミノ) ピリミジン (1 . 0 g) をホルムアミド (2m I ) と 1, 3—ジメ チルー 2—イミダゾリジノン (DM I ) (2m l ) の混合溶媒に溶解し、 スプレ 一ドライのフッ化カリウム (0. 5 g) を加え、 油浴中 80 ^で 3時間撹拌し た。
反応終了後、 水 (1 Om I ) を加え, 齚酸ェチルで抽出し、 水洗、 無水硫酸ナ 卜リウムで乾燥した。 6- (1-Promoethyl) 15-Chloro-4-1 [2- (4-Methoxyphenylethylamino) pyrimidine (1.0 g) is combined with formamide (2mI) and 1,3-dimethyl-2-imidazolidinone ( DMI) (2 ml) was dissolved in a mixed solvent, and spray-dried potassium fluoride (0.5 g) was added, followed by stirring in an oil bath at 80 ^ for 3 hours. After completion of the reaction, water (1 OmI) was added, extracted with ethyl acetate, washed with water, and dried over anhydrous sodium sulfate.
減圧下に酢酸ェチルを留去し、 得られた油状物をカラムクロマトグラフィー (ヮコ一ゲル C一 200、 トルエン:酢酸ェチル =20 : 1 -5 : 1溶出) に よって無色粉状態結晶である目的物を 0. 60 g (72. 1 %) 得た。 Ethyl acetate was distilled off under reduced pressure, and the obtained oil was subjected to column chromatography (ヮ co-gel C-200, toluene: ethyl acetate = 20: 1-5: 1) to give colorless powdery crystals. 0.60 g (72.1%) of the desired product was obtained.
(4) (土) 5—クロロー 6— (1一フル才ロェチル) 一 4一 [2— (4一トリフル ォロメトキシフエ二ル) ェチルァミノ] ピリミジン (化合物 1 4) の合成 (4) (Sat) 5-Chloro-6— (1 一 1-year-old roethyl) 1-41 [2- (4-Trifluoromethoxyphenyl) ethylamino] pyrimidine (Compound 14)
6— (1 —ブロモェチル) —5—クロロー 4— [2— (4一トリフル才ロメ卜 キフエニルェチルァミノ) ピリミジン (1. 0 g) をホルムアミド (2m l ) と 1, 3—ジメチルー 2—イミダゾリジノン (DM I ) (2m l ) の混合溶媒に溶 解し、 スプレードライのフッ化カリウム (0. 5 g) を加え、 油浴中 80°Cで 3 時間撹拌した。 6— (1—Bromoethyl) —5—Chloro—4— [2— (4-Trifluoromethyl kiphenylethylamino) Pyrimidine (1.0 g) is added to formamide (2 ml) and 1,3-dimethyl-2 —Dissolved in a mixed solvent of imidazolidinone (DMI) (2 ml), added spray-dried potassium fluoride (0.5 g), and stirred in an oil bath at 80 ° C for 3 hours.
反応終了後、 水 (1 Om I ) を加え, 齚酸ェチルで抽出し、 水洗、 無水硫酸ナ 卜リウ厶で乾燥した。 After completion of the reaction, water (1 OmI) was added, extracted with ethyl acetate, washed with water, and dried over anhydrous sodium sulfate.
減圧下に酢酸ェチルを留去し、 得られた油状物をカラムクロマトグラフィー (ヮコ一ゲル C一 200、 トルエン:舴酸ェチル =20 : 1〜5 : 1溶出) に よって無色粉状態結晶である目的物を 0. 60 g (69. 8%) 得た。 Ethyl acetate was distilled off under reduced pressure, and the obtained oil was subjected to column chromatography (Ecogel C-200, toluene: ethyl ether = 20: 1 to 5: 1) to give colorless powdery crystals. 0.60 g (69.8%) of the desired product was obtained.
- 1 H-NM R (C DC I 3) <5 p pm -1 H-NM R (C DC I 3 ) <5 p pm
2. 0 1 ~2. 03 (d, 3 H) , 2. 93〜 2. 98 ( t , 2 H) , 2.0 1 to 2.03 (d, 3H), 2.93 to 2.98 (t, 2H),
3. 75〜 3. 82 (q , 2H) , 5. 38〜 5. 46 (q, 1 H) , 3.75 to 3.82 (q, 2H), 5.38 to 5.46 (q, 1H),
5. 55 (s, 1 Η) , 7. 1 6〜 7. 27 (m, 5 H) , 5.55 (s, 1Η), 7.16 to 7.27 (m, 5 H),
8. 54 (s , 1 H) 8.54 (s, 1 H)
(5) (土) 5—クロロー 6- (1—フルォロェチル) 一 4一 [2— (4—トリフル 才ロメトキシフエ二ル) ェチルァミノ] ピリミジン (化合物 1 4) の合成 (5) (Sat) Synthesis of 5-chloro-6- (1-fluoroethyl) 1-41 [2- (4-trifluoromethoxyphenyl) ethylamino] pyrimidine (Compound 14)
6— (1一プロモェチル) —5—クロ口 _4一 [2— (4—トリフルォロメ卜 キフエニルェチルァミノ) ビリミジン (1. Og) を N—メチルホルムアミド
(2m l ) に溶解し、 スプレードライのフッ化カリウム (0. 5g) を加え、 油 浴中 80^で 3時間撹袢した。 6— (1—Promoethyl) —5—Black mouth_4—1—2— (4—Trifluorome kiphenylethylamino) Birimidine (1.Og) to N-methylformamide (2 ml), spray-dried potassium fluoride (0.5 g) was added, and the mixture was stirred in an oil bath at 80 80 for 3 hours.
反応終了後、 水 (1 Om I ) を加え, 酢酸ェチルで抽出し、 水洗、 無水硫酸ナ 卜リウ厶で乾燥した。 After completion of the reaction, water (1 OmI) was added, extracted with ethyl acetate, washed with water, and dried over anhydrous sodium sulfate.
減圧下に酔酸ェチルを留去し、 得られた油状物をカラ厶クロマ卜グラフィー (ヮコ一ゲル C一 200、 トルエン:酢酸ェチル =20 : 1 -5 : 1溶出) に よって無色粉状態結晶である目的物を 0. 58 g (67. 5%) 得た。 The ethyl sulphate was distilled off under reduced pressure, and the resulting oil was colorless powdered by column chromatography (ヮ 200, C-1 gel, eluting with toluene: ethyl acetate = 20: 1-5: 1). 0.58 g (67.5%) of the desired product as crystals was obtained.
(6)表 2中のその他の化合物 (3) の合成 (6) Synthesis of other compounds (3) in Table 2
前記の(1)〜(5)に記載の方法に準じて、 表 2中のその他の化合物 (3) を合成 した。 Other compounds (3) in Table 2 were synthesized according to the methods described in the above (1) to (5).
以上のようにして合成した化合物及びその物性を表 2に示す。
Table 2 shows the compounds synthesized as described above and their physical properties.
表 2 Table 2
以下、 本発明の実施例に対応する比較例 (特開平 7— 258223号公報記 載) を示す。 Hereinafter, comparative examples (described in JP-A-7-258223) corresponding to the examples of the present invention will be described.
比較例 1 (化合物 ( 4 ) の合成) Comparative Example 1 (Synthesis of Compound (4))
(1) 5—クロロー 6— (1一フル才ロェチル) ー4一 (2—フエニルェチルアミ ノ) ピリミジン (化合物 1 ) の合成 (1) Synthesis of 5-chloro-6- (1-full-year roethyl) -4-1- (2-phenylethylamino) pyrimidine (compound 1)
2—フエニルェチルァミン (1. 2 g) とトリエチルァミン (1. 2 g) とを トルエン (3 Om I ) に溶解し、 4, 5—ジクロロー 6— ( 1一フル才ロェチ
ル) ピリミジン (2. 0g) を加え、 4時間加熱運流した。 2-Phenylethylamine (1.2 g) and triethylamine (1.2 g) were dissolved in toluene (3 OmI), and 4,5-dichloro-6- (1 G) Pyrimidine (2.0 g) was added, and the mixture was heated for 4 hours.
反応終了後、 水を加え、 トルエンで抽出した。 抽出液を水洗、 無水硫酸ナトリ ゥ厶で乾燥後、 減圧下に溶媒を留去し、 得られた油状物をカラムクロマトグラフ ィー (ヮコ一ゲル C一 200、 トルエン:酔酸ェチル = 1 0 : 1溶出) によって 無色粉状結晶である目的物を 2. 3 g (82. 3%) 得た。 After completion of the reaction, water was added, and the mixture was extracted with toluene. The extract was washed with water, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The resulting oil was purified by column chromatography (Pecogel C-200, toluene: ethyl ethyl sulphate = 1). (0: 1 elution) to give 2.3 g (82.3%) of the desired product as colorless powdery crystals.
(2) 5—クロロー 6— (1一フルォロェチル) -4— 〔2— (4一メチルフエ二 ル) ェチルァミノ〕 ピリミジン (化合物 2) の合成 (2) Synthesis of 5-chloro-6- (1-fluoroethyl) -4- (2- (4-methylphenyl) ethylamino) pyrimidine (Compound 2)
2— (4一メチルフエニル) ェチルァミン (4. 1 g) と卜リエチルァミン (5, 0 g) とをトルエン (1 00m l ) に溶解し、 4, 5—ジクロロー 6- (1一クロロェチル) ピリミジン (6. 3 g) を加え、 3時間加熱通流した。 反応終了後、 水を加え、 トルエンで抽出した。 抽出液を水洗、 無水硫酸ナトリ ゥ厶で乾燥後、 減圧下に溶媒を留去し、 得られた油状物をカラムクロマ卜グラフ ィー (ヮコ一ゲル C一 200、 トルエン:酢酸ェチル = 1 0 : 1溶出) によって 無色粉状結晶である 5—クロロー 6— (1一クロロェチル) 一 4一 〔2— (4— メチルフエニル) ェチルァミノ〕 ピリミジンを 8. 4 g (90. 3%) 得た。 得られた、 5—クロロー 6— (1一クロロェチル) 一 4一 〔2— (4一メチル フエニル) ェチルァミノ〕 ピリミジン (3. 5 g) を N, N—ジメチルホル厶ァ ミド (50m l ) に溶解し、 醉酸カリウム (1. 4 g) と炭酸カリウム (1. 6 g) とを加え、 3時間加熱遠流した。 2- (4-Methylphenyl) ethylamine (4.1 g) and triethylamine (5.0 g) are dissolved in toluene (100 ml), and 4,5-dichloro-6- (1-chloroethyl) pyrimidine (6 3 g) was added, and the mixture was heated and passed for 3 hours. After completion of the reaction, water was added, and the mixture was extracted with toluene. The extract was washed with water, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The resulting oil was purified by column chromatography (P-gel C-200, toluene: ethyl acetate = 10%). : 1 elution) to obtain 8.4 g (90.3%) of colorless powdery crystals of 5-chloro-6- (1-1-chloroethyl) 1-41- [2- (4-methylphenyl) ethylamino] pyrimidine. Dissolve the obtained 5-chloro-6- (1-chloroethyl) 144- [2- (4-methylphenyl) ethylamino] pyrimidine (3.5 g) in N, N-dimethylformamide (50 ml). Then, potassium drunkate (1.4 g) and potassium carbonate (1.6 g) were added, and the mixture was heated and flowed for 3 hours.
反応終了後、 水を加え、 酸ェチルで抽出した。 抽出液を水洗、 無水硫酸ナ卜 リウムで乾燥後、 減圧下に溶媒を留去し、 得られた油状物をカラムクロマトダラ フィー (ヮコ一ゲル C一 200、 トルエン:酢酸ェチル =4 : 1溶出) によって 無色油状液体である 5—クロロー 6— (1一ァセ卜キシェチル) 一 4一 〔2— After the reaction was completed, water was added, and the mixture was extracted with ethyl acetate. The extract was washed with water, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The resulting oil was purified by column chromatography (ヮ co-gel C-200, toluene: ethyl acetate = 4: 1). (Elution), which is a colorless oily liquid 5-chloro-6-
(4一メチルフエニル) ェチルァミノ〕 ピリミジンを 2. 0 g (53. 1 %) 得 た。 (4-Monophenyl) ethylamino] pyrimidine (2.0 g, 53.1%) was obtained.
得られた、 5—クロ口— 6— (1一ァセ卜キシェチル) 一 4一 〔2— (4ーメ
チルフエニル) ェチルァミノ〕 ピリミジン (2. 3 g) をエタノール (25mThe obtained 5-black mouth 6- (1-acetoxyshethyl) 1-41 [2- (4-me Thiphenyl) ethylamino] pyrimidine (2.3 g) in ethanol (25m
I ) に溶解し、 1 N—水酸化ナ卜リウ厶水溶液 (1 3m l ) を加え、 約 60°CでI), add a 1N aqueous solution of sodium hydroxide (13 ml), and heat at about 60 ° C.
1時間加熱撹拌した。 The mixture was heated and stirred for 1 hour.
反応終了後、 水を加え、 醉酸ェチルで抽出した。 抽出液を水洗、 無水硫酸ナ卜 リウ厶で乾燥後、 減圧下に溶媒を留去し、 得られた油状物をカラムクロマ卜ダラ フィー (ヮコ一ゲル C一 200、 トルエン:齚酸ェチル =4 : "I溶出) によって 無色油状液体である 5—クロ口— 6— (1ーヒドロキシェチル) 一 4一 〔2— After the completion of the reaction, water was added, and the mixture was extracted with ethyl sulphate. The extract was washed with water, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The resulting oil was purified by column chromatography (ヮ 200, C-100 gel, toluene: ethyl acetate = 4). : A colorless oily liquid depending on the "I-elution". 5—Black mouth— 6— (1-Hydroxyethyl) 1-41 [2—
(4一メチルフエニル) ェチルァミノ〕 ピリミジンを 2. 0 g (定量的) 得た。 得られた、 5—クロ口- 6— (1ーヒドロキシェチル) 一 4一 〔2— (4-メ チルフエニル) ェチルァミノ〕 ピリミジン (1. 5 g) を塩化メチレン (30m(4-Monophenyl) ethylamino] pyrimidine (2.0 g, quantitative) was obtained. The obtained 5-chloro-6- (1-hydroxyethyl) 1.41- [2- (4-methylphenyl) ethylamino] pyrimidine (1.5 g) was treated with methylene chloride (30m2).
I ) に溶解し、 冷却攪拌下、 ジェチルアミノサルファー卜リフルオライド (DA ST) (0. 8 g) を滴下し、 室温で 1時間攪拌した。 I), and then, while cooling and stirring, getylaminosulfur trifluoride (DAST) (0.8 g) was added dropwise, followed by stirring at room temperature for 1 hour.
反応終了後、 冷却攪拌下、 ゆっくりと水を加え、 有機層を分取した。 有機層を 水洗、 無水硫酸ナトリウムで乾燥後、 減圧下に溶媒を留去し、 得られた油状物を カラムクロマトグラフィー (ヮコ一ゲル C一 200、 トルエン:酢酸ェチル = 1 0 : "1溶出) によって淡黄色油状液体である目的物を 1 · 0 g (66. 7%) 得 た。 After completion of the reaction, water was slowly added under cooling and stirring, and the organic layer was separated. The organic layer was washed with water and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained oil was purified by column chromatography (ヮ co-gel C-200, toluene: ethyl acetate = 10: 1 eluted) ) Gave 1.0 g (66.7%) of the desired product as a pale yellow oily liquid.
全工程の総収率は 3 1. 9 %である。 The total yield of all steps is 31.9%.
(3) 5—クロロー 6— (1一フル才ロェチル) 一 4一 〔2— (4ーメトキシフエ ニル) ェチルァミノ〕 ピリミジン (化合物 3) の合成 (3) Synthesis of 5-chloro-6- (1-fluoroethyl) -1 4- [2- (4-methoxyphenyl) ethylamino] pyrimidine (Compound 3)
5—クロロー 6— (1一クロロェチル) 一 4一 〔2— (4ーメ卜キシフエ二 ル) ェチルァミノ〕 ピリミジン (Ί . 5 g) を無水 N, N—ジメチルホルムアミ ド (30m I ) に溶解し、 セシウムフルオライド (1. 5 g) を加え、 1 20°C ~1 40でで 1 2時間攪袢反応した。 5-Chloro-6- (1-Chloroethyl) 1-41 [2- (4-Methoxyphenyl) ethylamino] Pyrimidine (Ί.5 g) is dissolved in anhydrous N, N-dimethylformamide (30 ml) Then, cesium fluoride (1.5 g) was added, and the mixture was stirred at 120 ° C. to 140 for 12 hours.
反応終了後、 室温まで冷却し水 (20m l ) と酢酸ェチル (20m l ) を加え 攪拌した後、 酔酸ェチル層を分取した。 水層を酢酸ェチルで再度抽出し、 先の酢
酸ェチル層に併せ水洗、 無水硫酸ナトリウムで乾燥後、 減圧下に酢酸ェチルを留 去し、 得られた油状物をカラムクロマトグラフィー (ヮコ一ゲル C一 200、 卜 ルェン: St酸ェチル =9 : 〗溶出) によって無色粉状結晶である目的物を 0. 5 g (35. 1 %) 得た。 After the completion of the reaction, the mixture was cooled to room temperature, water (20 ml) and ethyl acetate (20 ml) were added, and the mixture was stirred. Extract the aqueous layer again with ethyl acetate, After washing with water and drying over anhydrous sodium sulfate, the ethyl acetate was distilled off under reduced pressure, and the resulting oil was subjected to column chromatography (ヮ co-gel C-200, toluene: St-ethyl = 9). 0.5 g (35.1%) of the target compound as colorless powdery crystals.
(4) 5—クロロー 6— (1一フル才ロェチル) 一 4一 〔2— 〔4一 (トリフルォ ロメトキシ) フエニル〕 ェチルァミノ〕 ピリミジン (化合物 1 4) の合成 2— 〔4— (トリフル才ロメ卜キシ) フエニル〕 ェチルァミン (2. 05 g) と卜リエチルァミン (3. 0 g) とをトルエン (20m l ) に溶解し、 4, 5- ジクロロー 6— (1一フル才ロェチル) ピリミジン (2. 0 g) を加え、 約 60 で 4時間擾拌した。 (4) Synthesis of 5-chloro-6- (1-fluoroethylene) 1-41 [2- [4-1 (trifluoromethoxy) phenyl] ethylamino] pyrimidine (compound 14) 2- [4- (trifluoromethyl) Xy) phenyl] ethylamine (2.05 g) and triethylamine (3.0 g) were dissolved in toluene (20 ml), and the mixture was dissolved in 4,5-dichloro-6- (1-one-year-old roethyl) pyrimidine (2.0). g) and stirred at about 60 for 4 hours.
反応終了後、 水を加え、 卜ルェンで抽出した。 抽出液を水洗、 無水硫酸ナ卜リ ゥムで乾燥後、 減圧下に溶媒を留去し、 得られた油状物をカラムクロマトグラフ ィー (ヮコ一ゲル C一 200、 トルエン: 酸ェチル = 1 0 : 1溶出) によって 淡黄色粉状結晶である目的物を 2. 6 g (7 1. 5%) 得た。 After the reaction was completed, water was added, and the mixture was extracted with toluene. The extract was washed with water, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The resulting oil was purified by column chromatography (Co-gel C-200, toluene: acid ethyl = (10: 1)) to obtain 2.6 g (71.5%) of the desired product as pale yellow powdery crystals.
本発明と比較例における化合物 (4) の製造結果の比較を、 次の表 3に示す。
Table 3 below shows a comparison of the production results of the compound (4) in the present invention and Comparative Examples.
3 Three
参考例 Reference example
以下、 比較例 (特開平 7— 258223号公報に記載) において使用する原料 化合物 (5) の合成法 (特開平 5— 1 944 1 7号公報及び特開平 5— 320 1 41号公報に記載) を示す。 Hereinafter, a method for synthesizing the starting compound (5) used in Comparative Examples (described in JP-A-7-258223) (described in JP-A-5-194417 and JP-A-5-320141) Is shown.
参考例 1 (化合物 ( 5 ) の合成) Reference Example 1 (Synthesis of Compound (5))
(1) 4, 5—ジクロロー 6— (1一フル才ロェチル) ピリミジンの合成 (1) Synthesis of 4,5-dichloro-6- (1-one-year-old rotyl) pyrimidine
6— ( 1 -クロ口ェチル) 一 4, 5—ジクロロピリミジン (1 0. 2 g) を N, N—ジメチルホルムアミド (1 50m l ) に溶解し、 酢酸カリウム (1 0. 2 g) と炭酸カリウム (1 2. 0 g) を加え、 約 60°Cで 3時間攬拌した。 反応液に水 (200m l ) を加え、 分離する油状物をトルエンで抽出し、 水洗 後、 無水硫酸ナトリウムで乾燥した。 次いで、 減圧下に溶媒を留去し、 得られた 油状物をカラムクロマトグラフィー (ヮコ一ゲル C一 200、 トルエン:酢酸ェ チル = 1 0 : 1溶出) によって淡黄色の液体である 4, 5—ジクロロー 6— (1 ーァセトキシェチル) ピリミジンを 5. 2 g (45. 9%) 得た。 6— (1-Chloroethyl) 1,4,5-Dichloropyrimidine (10.2 g) is dissolved in N, N-dimethylformamide (150 ml), and potassium acetate (10.2 g) and carbonic acid are dissolved. Potassium (12.0 g) was added, and the mixture was stirred at about 60 ° C for 3 hours. Water (200 ml) was added to the reaction solution, and the separated oil was extracted with toluene, washed with water, and dried over anhydrous sodium sulfate. Then, the solvent was distilled off under reduced pressure, and the obtained oil was purified by column chromatography (ヮ -gel C-200, toluene: ethyl acetate = 10: 1 elution) to give a pale yellow liquid. 5.2 g (45.9%) of 5-dichloro-6- (1-acetoxicetyl) pyrimidine was obtained.
4, 5—ジクロロー 6— (1—ァセトキシェチル) ピリミジン (4. O g) を テ卜ラヒドロフラン (50m l ) に溶解し、 攪拌下に 1 N—水酸化ナトリウム水 溶液 (30m l ) をゆつくりと滴下した。 滴下後、 さらに 1時間室温で攒拌し、 反応を完結した。 次いで、 減圧下に溶媒を留去し、 得られた油状物をカラムクロ マトグラフィー (ヮコ一ゲル C一 200、 トルエン:齚酸ェチル =5 : 1溶出) によって淡黄色の液体である 4, 5—ジクロロー 6— (1ーヒドロキシェチル) ピリミジンを 2. 8 g (85. 4%) 得た。 Dissolve 4,5-dichloro-6- (1-acetoxitytyl) pyrimidine (4.O g) in tetrahydrofuran (50 ml) and slowly add 1N-aqueous sodium hydroxide solution (30 ml) with stirring. It was dropped. After the dropwise addition, the mixture was further stirred at room temperature for 1 hour to complete the reaction. Then, the solvent was distilled off under reduced pressure, and the resulting oil was subjected to column chromatography (ク ロ co-gel C-200, toluene: ethyl acetate = 5: 1 elution) to give a pale yellow liquid 4,5. —Dichloro-6— (1-hydroxyethyl) pyrimidine (2.8 g, 85.4%) was obtained.
得られた 4, 5—ジクロロー 6— (1ーヒドロキシェチル) ピリミジン (2. 1 g) をジクロロメタン (1 5m l ) に溶解し、 冷却、 攪拌下にジェチルァミノ サルファー卜リフルオライド (2· 0g) を滴下し、 さらに 1時間室温で攪拌 し、 反応を完結した。 反応液に冷水 (20m l ) を加え、 ジクロロメタン餍を分 取し、 水洗後、 無水硫酸ナ卜リウ厶で乾燥した。 次いで、 減圧下に溶媒を留去
し、 得られた油状物をカラムクロマトグラフィー (ヮコ一ゲル C一 200、 クロ 口ホルム溶出) によって淡黄色の液体である目的物を 1. 3 g (6 1. 3%) 得 た。 The obtained 4,5-dichloro-6- (1-hydroxyethyl) pyrimidine (2.1 g) was dissolved in dichloromethane (15 ml), and cooled and stirred, and getylaminosulfur trifluoride (2.0 g) was added thereto. The mixture was added dropwise and further stirred at room temperature for 1 hour to complete the reaction. Cold water (20 ml) was added to the reaction solution, dichloromethane was separated, washed with water, and dried over anhydrous sodium sulfate. Next, the solvent is distilled off under reduced pressure. The obtained oil was subjected to column chromatography (Pelcogel C-200, elution with chloroform) to give 1.3 g (61.3%) of the target compound as a pale yellow liquid.
全工程の総収率は 24. 0 %である。 The total yield of all steps is 24.0%.
参考例 2 (化合物 (7) の合成) Reference Example 2 (Synthesis of Compound (7))
(2) 6- (1—クロロェチル) 一 4, 5—ジクロ口ピリミジンの合成 (2) Synthesis of 6- (1-chloroethyl) -1,4,5-dichropyrimidine
4, 5-ジクロロー 6_ェチルピリミジン (270 g) をジクロロメタン (7 50m l ) に溶解し、 30〜35でに加温、 攪袢下に塩素ガスを 2時間吹き込ん だ。 反応終了後、 反応液に窒素ガスを吹き込み、 過剰に溶存する塩素ガスを除い た。 次いで、 減圧下にジクロロメタンを留去し、 得られた油状物を減圧蒸留する ことによって淡黄色の液体である目的物を 240 g得た。 4,5-Dichloro-6-ethylpyrimidine (270 g) was dissolved in dichloromethane (750 ml), heated at 30 to 35, and blown with chlorine gas for 2 hours with stirring. After completion of the reaction, nitrogen gas was blown into the reaction solution to remove excessively dissolved chlorine gas. Then, dichloromethane was distilled off under reduced pressure, and the obtained oil was distilled under reduced pressure to obtain 240 g of the target substance as a pale yellow liquid.
参考例 3 (化合物 (1 B) の合成) Reference Example 3 (Synthesis of Compound (1B))
(1) (土) 6— (1ーブロモェチル) 一 5—クロロー 4一 (2—フエニルェチルァ ミノ) ピリミジン (化合物 1 -1) の合成 (1) (Sat) Synthesis of 6- (1-bromoethyl) -1-5-chloro-4-1 (2-phenylethylamino) pyrimidine (Compound 1-1)
2—フエニルェチルァミン (1. 2 g) と卜リエチルァミン (1. 2 g) を卜 ルェン (30m l ) に溶解し、 4一プロモー 6— (1一プロモェチル) 一 5—ク ロロピリミジン (3. 0 g) を加え、 約 40でで 4時間撹拌した。 2-Phenylethylamine (1.2 g) and triethylamine (1.2 g) were dissolved in toluene (30 ml), and then 4-promo 6- (1-promoethyl) -15-chloropyrimidine (3.0 g) and stirred at about 40 for 4 hours.
反応終了後、 水を加え、 トルエンで抽出した。 After completion of the reaction, water was added, and the mixture was extracted with toluene.
抽出液を水洗、 無水硫酸ナトリウムで乾燥後、 減圧下に溶媒を留去し、 得られ た油状物をカラムクロマトグラフィー (ヮコ一ゲル C一 200、 トルエン:酢酸 ェチル =1 0 : 1溶出) によって無色粉状結晶である目的物を 2. 9 g (85. The extract is washed with water, dried over anhydrous sodium sulfate, the solvent is distilled off under reduced pressure, and the obtained oil is subjected to column chromatography (ヮ co-gel C-200, toluene: ethyl acetate = 10: 1 elution). 2.9 g (85.
3 %) 得た。 3%).
• m. p. Ί 03〜 1 05°C • m.p.Ί 03〜 05 ° C
(2) (土〉 6— (1—プロモェチル) 一 5—クロロー 4— [2— (4一トリフル才 ロメ卜キシフエニル) ェチルァミノ] ピリミジン (化合物 1 -7) の合成 (2) (Sat) Synthesis of 6- (1-promoethyl) -1-5-chloro-4- [2- (4-trifluromethyoxyphenyl) ethylamino] pyrimidine (compounds 1-7)
2— (4ー卜リフル才ロメ卜キシフエニル) ェチルァミン (3. 0 g) と卜リ
ェチルァミン (3. 0 g) をトルエン (50m I ) に溶解し、 4一ブロモ—6— ( 1一プロモェチル) 一 5—クロ口ピリミジン (4. 5 g) を加え、 約 40°Cで 3時間撹拌した。 2- (4-triflurescent romoxyphenyl) ethylamine (3.0 g) Dissolve ethylethylamine (3.0 g) in toluene (50 ml), add 4-bromo-6- (1-promoethyl) -15-chloropyrimidine (4.5 g), and add it at about 40 ° C for 3 hours. Stirred.
反応終了後、 水を加え、 トルエンで抽出した。 抽出液を水洗、 無水硫酸ナ卜リ ゥ厶で乾燥後、 減圧下に溶媒を留去し、 得られた油状物をカラムクロマ卜グラフ ィー (ヮコ一ゲル C一 200、 トルエン:酢酸ェチル = 1 0 : 1溶出) によって 無色粉状結晶である目的物を 5. 9 g (92. 7%) 得た。 After completion of the reaction, water was added, and the mixture was extracted with toluene. The extract was washed with water, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The obtained oil was purified by column chromatography (Cocogel C-200, toluene: ethyl acetate = (10: 1 elution) to give 5.9 g (92.7%) of the target compound as colorless powdery crystals.
• m. p. 9 1〜9 1. 5°C • m.p. 9 1 to 9 1.5 ° C
(3) (土) 6— (1一プロモェチル) 一 5—クロ口- 4一 [2— (4一二卜口フエ ニル) ェチルァミノ] ピリミジン (化合物 1 -10) の合成 (3) (Sat) Synthesis of 6- (1-promoethyl) -1-5-clo-4-1- [2-((412-phenyl) ethylamino] pyrimidine (Compounds 1-10)
2— (4一二卜口フエニル) ェチルァミン塩酸塩 (3. 0 g) をトルエン (5 0m l ) に懸潘させ、 卜リエチルァミン (3. 0 g) と 6— (1—プロモェチ ル) 一 4, 5—ジクロ口ピリミジン (3. 8 g) を加え、 約 50°Cで 5時間撹拌 した。 2- (4-N-phenyl phenyl) ethylamine hydrochloride (3.0 g) is suspended in toluene (50 ml), and triethylamine (3.0 g) and 6- (1-promoethyl) are added. , 5-Dichrolic pyrimidine (3.8 g) was added, and the mixture was stirred at about 50 ° C for 5 hours.
反応終了後、 水を加え、 トルエンで抽出した。 抽出液を水洗、 無水硫酸ナトリ ゥ厶で乾燥後、 減圧下に溶媒を留去し、 得られた油状物をカラムクロマ卜グラフ ィー (ヮコ一ゲル C一 200、 トルエン:酢酸ェチル = 1 0 : 1溶出) によって 無色粉状結晶である目的物を 5. 1 g (88. 2%) 得た。 After completion of the reaction, water was added, and the mixture was extracted with toluene. The extract was washed with water, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The resulting oil was purified by column chromatography (P-gel C-200, toluene: ethyl acetate = 10%). : 1 elution) to give 5.1 g (88.2%) of the target compound as colorless powdery crystals.
• m. p. 1 1 4〜 1 1 6*C • m.p. 1 1 4 to 1 16 * C
(4)表 4中のその他の化合物 (1 B) の合成 (4) Synthesis of other compounds (1 B) in Table 4
前記の )〜 (3)に記載の方法に準じて、 表 4中のその他の化合物 (1 B) を合 成した。 Other compounds (1B) in Table 4 were synthesized according to the methods described in the above) to (3).
以上のようにして合成した化合物及びその物性を表 4に示す。
表 4 Table 4 shows the compounds synthesized as described above and their physical properties. Table 4
本発明によれば、 医薬並びに農園芸用の有害生物防除剤等として有用な 4ーァ ミノー 5—クロロー 6— (1一フル才ロェチル) ピリミジン化合物の工業的製法 を提供することができる。
According to the present invention, it is possible to provide an industrial process for producing 4-amino-5-chloro-6- (11-full-year-old rotyl) pyrimidine compound useful as a medicament, a pesticide for agricultural and horticultural use, and the like.
Claims
請 求 の 範 囲 次式 い A) Range of claim: A)
式中、 Rは水素原子, 炭素数 1〜 4個のアルキル基, 炭素数〗〜 4個のアル コキシ基, ハロゲン原子, 無 S換又はハロゲン原子, 炭素数!〜 4個のアル キル基, 炭素数 〜 4個のアルコキシ基, 炭素数 1〜 4個のハロアルキル基 の少なくとも 1つを置換基として有するベンゾィル基, 炭 ¾数 1〜4個のハ 口アルキル基, 炭素数 1 ~ 4個のハロアルコキシ基, 炭素数 2〜5個のハロ アルキルカルボニル基, 炭素数〗〜 4個のアルキルスルホニル才キシ基, 炭 素数 〜 4個の八口アルキルスルホニル才キシ基, (炭素数 1〜 4個のアル コキシ基) ィミノべンジル基, 2—フエ二ルーし 3—ジ才キソラニル基, 無置換又はハロゲン原子, 水酸基の少なくとも 1つを置換基として有するベ ンジル基, 無 S换又はハロゲン尿子, 炭素数〗〜 4個の八口アルキル基の少 なくとも 1つを置換基として有するフエノキシ基, 炭素数 2〜5個のハロア ルケニル才キシ基, 炭素数 2〜 5個のアルケニル才キシ基, 卜リ (炭素数 1 〜4個のアルキル) シリルアルコキシ基, 炭素数〗〜 4個のアルキルチ才 基, 水酸基, 無 換又はハロゲン原子, 炭紊数 1〜4個のハロアルキル基の 少なくとも 1つを置換基として有するピリジル才キシ基, 炭素数 1〜4個の アルキルスルホニル基, 炭素数 1〜4個のアルキルスルフィニル基, 炭素数 1〜 4個の八口アルキルスルフィニル基, 炭素数 1〜 4個のハロアルキルチ 才基, 炭素数 1 〜 4個のアルキルカルボニル基, 炭素数 2〜 5個のアルキニ ル才キシ基, 或いはニトロ基を表し, nは〗〜 5の整数を表す,
で示される 4一アミノー 5—クロ口— 6— (1一クロロェチル) ピリミジン化合 物と In the formula, R is a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a halogen atom, a non-S-substituted or halogen atom, and a carbon number! Up to 4 alkyl groups, up to 4 carbon alkoxy groups, 1 to 4 haloalkyl groups as substituents, benzoyl group having 1 to 4 carbon atoms, 1 to 4 carbon haloalkyl groups A haloalkoxy group having 1 to 4 carbon atoms, a haloalkylcarbonyl group having 2 to 5 carbon atoms, an alkylsulfonyloxy group having 4 to 4 carbon atoms, an octaalkylsulfonyloxy group having 4 to 4 carbon atoms , (Alkoxy group having 1 to 4 carbon atoms) iminobenzyl group, 2-phenyl-2-oxolanyl group, unsubstituted or benzyl group having at least one of a halogen atom and a hydroxyl group as a substituent , No S or halogen urine, phenoxy group having at least one of octaalkyl group having 4 to 4 carbon atoms as a substituent, haloalkenyl group having 2 to 5 carbon atoms, 2 carbon atoms ~ 5 alkenyls , Tri (alkyl having 1 to 4 carbon atoms) at least one of a silylalkoxy group, an alkylthio group having 1 to 4 carbon atoms, a hydroxyl group, a substituted or halogen atom, and a haloalkyl group having 1 to 4 carbon atoms A pyridyl group having 1 to 4 carbon atoms, an alkylsulfonyl group having 1 to 4 carbon atoms, an alkylsulfinyl group having 1 to 4 carbon atoms, an octaalkylsulfinyl group having 1 to 4 carbon atoms, 1 to 4 carbon atoms Represents a haloalkyl group, an alkylcarbonyl group having 1 to 4 carbon atoms, an alkynyl group having 2 to 5 carbon atoms, or a nitro group, and n represents an integer of〗 to 5, 4-Amino-5-chloro-6- (1-chloroethyl) pyrimidine compound represented by
次式 (2) : The following equation (2):
-F (2) -F (2)
式中、 Mはアルカリ金属を表す, In the formula, M represents an alkali metal,
で示されるアルカリ金厲フッ素化合物類とを With alkali gold-fluorine compounds represented by
次式 ( 3 ) : The following equation (3):
(R,) 4NX (3) (R,) 4 NX (3)
式中、 R1は炭素数 1〜 4個のアルキル基, ベンジル基又はフエ二ル基を表 す。 Xはハロゲン原子を表す, In the formula, R 1 represents an alkyl group having 1 to 4 carbon atoms, a benzyl group or a phenyl group. X represents a halogen atom,
で示される第四級アンモニゥ厶塩の存在下に反応させることを特徴とする 次式 (4 A) : Wherein the reaction is carried out in the presence of a quaternary ammonium salt represented by the following formula (4A):
式中、 R及び nは前記と同義である, Wherein R and n are as defined above,
で示され 4一アミノー 5—クロロー 6— (1一フル才ロェチル) ピリミジン化合 物の製法。 A method for producing 4-amino-5-chloro-6- (1-full-year rotyl) pyrimidine compound.
2. 室温から使用する溶媒の沸点以下の溫度範囲において、 2~5時間、 反応 が行われる請求の範囲第 1項記載の製法。 2. The process according to claim 1, wherein the reaction is carried out for 2 to 5 hours in a temperature range from room temperature to the boiling point of the solvent to be used or lower.
3. 反応温度が 1 1 0〜〗 30 eCである請求の範囲第 1項記載の製法。 3. The reaction temperature is 1 1 0〗 30 e C in preparation ranging first claim of claim is.
4. 式 (3) で示される化合物が、 塩化トリェチルベンジルアンモニゥ厶, 塩 化テ卜ラメチルアンモニゥ厶, 臭化トリェチルベンジルアンモニゥ厶, 塩化卜リ
ブチルベンジルアンモニゥ厶, 塩化トリメチルベンジルアンモニゥ厶, 奥化トリ メチルフエ二ルアンモニゥ厶, 臭化テトラメチルアンモニゥ厶, 奧化テトラェチ ルアンモニゥ厶, 奥化テトラー Π-プチルアンモニゥ厶, ヨウィ匕テ卜ラメチルン モニゥ厶及びョゥ化テトラー n -ブチルァンモニゥ厶から成る群より選ばれたも のである請求の範囲第 1項記載の製法。 4. The compound represented by the formula (3) is obtained by converting triethylbenzylammonium chloride, tetramethylammonium chloride, triethylbenzylammonium bromide, Butylbenzylammonium, Trimethylbenzylammonium chloride, Trimethylphenylammonium iodide, Tetramethylammonium bromide, Tetraethylammonium iodide, Tetramethylammonium iodide, Tetramethylammonium iodide, 2. The process according to claim 1, wherein the process is selected from the group consisting of: and tetra-n-butylammonium iodide.
5. 式 (2) で示される化合物がスプレードライのフッ化カリウムである請求 の範囲第 1項記載の製法。 5. The method according to claim 1, wherein the compound represented by the formula (2) is spray-dried potassium fluoride.
6. 化合物 (2) が、 化合物 (1 A) に対して 1 ~1 0倍モル、 化合物 (3) が、 化合物 (1 A) に対して 0. 01〜2倍モルの量で使用される請求の範囲第 1項記載の製法。 6. Compound (2) is used in an amount of 1 to 10 times the molar amount of compound (1A), and compound (3) is used in an amount of 0.01 to 2 times the molar amount of compound (1A). The production method according to claim 1.
7. 化合物 (2) が、 化合物 (1 A) に対して 3〜5倍モル、 化合物 (3) が、 化合物 (1 A) に対して 0. 3〜1. 0倍モルの量で使用される請求の範囲 第 1項記載の製法。 7. The compound (2) is used in an amount of 3 to 5 times the molar amount of the compound (1 A), and the compound (3) is used in an amount of 0.3 to 1.0 times the molar amount of the compound (1 A). The production method according to claim 1.
8 次式 (1 B) : The following equation (1B):
式中、 R' は水素原子, 炭素原子数 〜 4個のアルキル基, 炭素原子数 1〜 4個のアルコキシ基, ハロゲン原子, 炭素原子数 1〜 4個のハロアルキル 基、 炭素原子数 1〜4個のハロアルコキシ基及び二卜口基を表す, で示される 4一アミノー 5—クロロー 6— (1一プロモェチル) ピリミジン化合 物と
次式 (2) : In the formula, R ′ is a hydrogen atom, an alkyl group having 4 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a halogen atom, a haloalkyl group having 1 to 4 carbon atoms, and a carbon atom having 1 to 4 carbon atoms. And a 4-amino-5-chloro-6- (1-promoethyl) pyrimidine compound represented by The following equation (2):
M— F (2) M—F (2)
式中、 Mはアルカリ金属を表す, In the formula, M represents an alkali metal,
で示されるアルカリ金属フッ素ィヒ合物とを、 And an alkali metal fluorine compound represented by
ホルムアミド、 N—メチルホルムアミド、 又はホルムアミドもしくは N—メチ ルホルムアミドと 1 , 3—ジメチルー 2—イミダゾリジノンとの混合物を溶媒と して反応させることを特徴とする Characterized by reacting formamide, N-methylformamide, or a mixture of formamide or N-methylformamide with 1,3-dimethyl-2-imidazolidinone as a solvent
次式 (4 B) : The following equation (4B):
式中、 Rは前記と同義である, Wherein R is as defined above,
で示される 4一アミノー 5—クロロー 6— (1 —フル才ロェチル) ピリミジン化 合物の製法。 A method for producing 4-amino-5-chloro-6- (1-fluroletyl) pyrimidine compound represented by the formula:
9. 室温から使用する溶媒の沸点以下の温度範囲において、 1〜3時間、 反応 が行われる請求の範囲第 8項記載の製法。 9. The process according to claim 8, wherein the reaction is carried out for 1 to 3 hours in a temperature range from room temperature to the boiling point of the solvent to be used.
1 0. 反応温度が 50〜 1 00でである請求の範囲第 8項記載の製法。 10. The process according to claim 8, wherein the reaction temperature is 50 to 100.
1 1. 式 (2) で示される化合物がスプレードライのフッ化カリウムである請 求の範囲第 8項記載の製法。 1 1. The process according to claim 8, wherein the compound represented by the formula (2) is spray-dried potassium fluoride.
1 2. 化合物 (2) が、 化合物 (1 B) に対して 1〜1 0倍モルの量で使用さ れる請求の範囲第 8項記載の製法。
12. The process according to claim 8, wherein the compound (2) is used in an amount of 1 to 10 moles per mole of the compound (1B).
1 3. 化合物 (2) が、 化合物 (1 B) に対して 2〜 5倍モルの量で使用され る請求の範囲第 8項記載の製法。 13. The process according to claim 8, wherein the compound (2) is used in an amount of 2 to 5 moles per mole of the compound (1B).
1 4. 溶媒が、 化合物 (1 B) が 5〜80重量%になるような量で使用される 請求の範囲第 8項記載の製法。 14. The process according to claim 8, wherein the solvent is used in an amount such that the amount of the compound (1B) is 5 to 80% by weight.
1 5. 溶媒が、 化合物 (1 B) が 1 0~50重量%になるような量で使用され る請求の範囲第 8項記載の製法。
1 5. The process according to claim 8, wherein the solvent is used in such an amount that the compound (1B) becomes 10 to 50% by weight.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19028096A JPH1036355A (en) | 1996-07-19 | 1996-07-19 | Method for producing 4-amino-5-chloro-6- (1-fluoroethyl) pyrimidine derivative |
JP8/190280 | 1996-07-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998003272A1 true WO1998003272A1 (en) | 1998-01-29 |
Family
ID=16255545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1997/002475 WO1998003272A1 (en) | 1996-07-19 | 1997-07-17 | Processes for the preparation of 4-amino-5-chloro-6-(1-fluoroethyl)pyrimidine compounds |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPH1036355A (en) |
WO (1) | WO1998003272A1 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013113787A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
WO2013113776A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
WO2013113720A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
WO2013113778A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
WO2013113863A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
WO2013113773A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
WO2013113719A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds ii |
WO2013113782A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
WO2013113781A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds i |
WO2013113716A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
US9072301B2 (en) | 2012-02-03 | 2015-07-07 | Basf Se | Fungicidal pyrimidine compounds |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999052880A1 (en) * | 1998-04-14 | 1999-10-21 | Ube Industries, Ltd. | 5-iodo-4-phenethylaminopyrimidine derivatives, intermediates thereof, process for producing the same and agricultural/horticultural pesticides |
CN103772369B (en) | 2012-10-25 | 2016-12-21 | 沈阳中化农药化工研发有限公司 | Homopiperony lamine compounds and application thereof |
US9770026B2 (en) * | 2012-10-25 | 2017-09-26 | Shenyang Sinochem Agrochemicals R&D Co., Ltd. | Substituted pyrimidine compound and uses thereof |
CN103772293B (en) * | 2012-10-25 | 2015-09-09 | 中国中化股份有限公司 | Fluorine-containing pyrimidines and purposes |
CN103772294B (en) * | 2012-10-25 | 2015-09-09 | 中国中化股份有限公司 | Phenoxy pyrimidine aminated compounds and purposes |
CN104710409B (en) | 2013-12-13 | 2019-06-04 | 沈阳中化农药化工研发有限公司 | Pyrazolyl pyrimidines aminated compounds and purposes |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01301636A (en) * | 1988-05-31 | 1989-12-05 | Central Glass Co Ltd | Production of 1,2,2,2-tetrafluoroethyl difluoromethyl ether |
JPH04164068A (en) * | 1990-10-26 | 1992-06-09 | Asahi Glass Co Ltd | Method for producing fluorinated pyridines |
-
1996
- 1996-07-19 JP JP19028096A patent/JPH1036355A/en active Pending
-
1997
- 1997-07-17 WO PCT/JP1997/002475 patent/WO1998003272A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01301636A (en) * | 1988-05-31 | 1989-12-05 | Central Glass Co Ltd | Production of 1,2,2,2-tetrafluoroethyl difluoromethyl ether |
JPH04164068A (en) * | 1990-10-26 | 1992-06-09 | Asahi Glass Co Ltd | Method for producing fluorinated pyridines |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013113787A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
WO2013113776A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
WO2013113720A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
WO2013113778A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
WO2013113788A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
WO2013113863A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
WO2013113791A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
WO2013113773A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
WO2013113719A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds ii |
WO2013113782A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
WO2013113781A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds i |
WO2013113716A1 (en) | 2012-02-03 | 2013-08-08 | Basf Se | Fungicidal pyrimidine compounds |
US9055750B2 (en) | 2012-02-03 | 2015-06-16 | Basf Se | Fungicidal pyrimidine compounds |
US9072301B2 (en) | 2012-02-03 | 2015-07-07 | Basf Se | Fungicidal pyrimidine compounds |
Also Published As
Publication number | Publication date |
---|---|
JPH1036355A (en) | 1998-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998003272A1 (en) | Processes for the preparation of 4-amino-5-chloro-6-(1-fluoroethyl)pyrimidine compounds | |
JP6181166B2 (en) | Process for the preparation of certain 2- (pyridin-3-yl) thiazoles | |
AU2013272011B2 (en) | Processes to produce certain 2-(pyridine-3-yl)thiazoles | |
CN1875006B (en) | Preparation method of fluoromethyl substituted heterocycle | |
CN112321477A (en) | A kind of 3,5-dimethyl-4-sulfonyl-1H-pyrrole compound, preparation method and use | |
UA73735C2 (en) | A method for the preparation of substituted pirimidines (variants) | |
JP2851524B2 (en) | Method for producing sulfonylurea derivative | |
TW200540160A (en) | Process for the production of 5-difluoromethoxy -4-thiomethylpyrazoles | |
JPH1112253A (en) | Method for producing 4-amino-5-chloro-6- (1-fluoroethyl) pyrimidine derivative | |
JP4538993B2 (en) | Process for producing β-ketonitrile derivatives | |
WO2014124878A1 (en) | Process for the preparation of bis-dihaloalkyl pyrazoles | |
WO1999044997A1 (en) | 6-(α-FLUOROALKYL)-4-PYRIMIDONES AND PROCESS FOR PRODUCING THE SAME | |
JP4075357B2 (en) | 4,5-disubstituted-1,2,3-triazole and process for producing the same | |
US20190330184A1 (en) | 4-((6-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3(5-mercapto-1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation | |
JP3887893B2 (en) | Process for producing 4- [2- (4- (trifluoromethoxy) phenyl) ethylamino] pyrimidine derivative, production intermediate and process for producing the same | |
Beck et al. | A new synthesis of 1‐aryl‐5‐cyano‐1H‐pyrazole‐4‐carboxylic acid, ethyl esters | |
JP4055246B2 (en) | 5-chloro-6- (α-fluoroalkyl) -4-pyrimidone and process for producing the same | |
JP2003089691A (en) | 6- (1-Fluoroethyl) pyrimidines and production method thereof | |
JP2023503572A (en) | Process for the synthesis of 2-(5-isoxazolyl)-phenol | |
CA3162102A1 (en) | Process for synthesis of a 2-thioalkyl pyrimidine | |
KR100467979B1 (en) | Fluorine-substituted heterocyclic compounds as intermediate for synthesis of agrochemical and medicinal antagonist and method for preparing thereof | |
JPH0543557A (en) | Halosulfonylcarbamoyltriazole derivative | |
WO2010116121A1 (en) | Processes for making isoxazoline derivatives | |
KR20030031795A (en) | Fluorine-substituted heterocyclic compounds as intermediate for synthesis of agrochemical and medicinal antagonist and method for preparing thereof | |
JPS6277371A (en) | Fluorine-containing pyrazole derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): BR CN KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |